Gene Symbol | Gene ID | Gene Info |
---|---|---|
Ascl2
|
ENSMUSG00000009248.5 | achaete-scute family bHLH transcription factor 2 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr7_142967941_142968391 | Ascl2 | 551 | 0.696499 | 0.44 | 7.8e-04 | Click! |
chr7_142969058_142969209 | Ascl2 | 131 | 0.946441 | 0.44 | 8.4e-04 | Click! |
chr7_142968524_142968762 | Ascl2 | 74 | 0.961597 | 0.43 | 9.4e-04 | Click! |
chr7_142967489_142967939 | Ascl2 | 1003 | 0.455201 | -0.42 | 1.6e-03 | Click! |
chr7_142969241_142969455 | Ascl2 | 84 | 0.959412 | 0.37 | 5.6e-03 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr9_62536098_62537614 | 16.64 |
Coro2b |
coronin, actin binding protein, 2B |
104 |
0.97 |
chr14_123626303_123627238 | 16.25 |
Nalcn |
sodium leak channel, non-selective |
106 |
0.98 |
chr4_20777672_20778960 | 15.79 |
Nkain3 |
Na+/K+ transporting ATPase interacting 3 |
251 |
0.96 |
chr5_112237414_112237869 | 15.18 |
Miat |
myocardial infarction associated transcript (non-protein coding) |
8246 |
0.12 |
chr12_111693687_111693960 | 13.86 |
Gm36635 |
predicted gene, 36635 |
9259 |
0.09 |
chr11_4947352_4948069 | 13.27 |
Nefh |
neurofilament, heavy polypeptide |
354 |
0.82 |
chr16_65815403_65815951 | 13.06 |
Vgll3 |
vestigial like family member 3 |
48 |
0.98 |
chr18_5978462_5978815 | 12.62 |
Gm34804 |
predicted gene, 34804 |
33455 |
0.17 |
chr9_112207779_112208199 | 12.30 |
Arpp21 |
cyclic AMP-regulated phosphoprotein, 21 |
9272 |
0.2 |
chr6_77979415_77979709 | 12.29 |
Ctnna2 |
catenin (cadherin associated protein), alpha 2 |
2 |
0.98 |
chr7_3331892_3332177 | 12.12 |
Cacng7 |
calcium channel, voltage-dependent, gamma subunit 7 |
921 |
0.35 |
chr5_111220876_111221370 | 11.84 |
Ttc28 |
tetratricopeptide repeat domain 28 |
4335 |
0.22 |
chr11_29774406_29774599 | 11.56 |
Eml6 |
echinoderm microtubule associated protein like 6 |
10269 |
0.17 |
chr16_37584223_37584651 | 11.46 |
Hgd |
homogentisate 1, 2-dioxygenase |
4155 |
0.17 |
chr13_92425671_92426978 | 11.45 |
Ankrd34b |
ankyrin repeat domain 34B |
17 |
0.95 |
chr3_92080488_92081161 | 11.30 |
Lor |
loricrin |
2318 |
0.17 |
chr11_47641094_47641305 | 11.24 |
Sgcd |
sarcoglycan, delta (dystrophin-associated glycoprotein) |
3730 |
0.37 |
chr17_15371910_15372469 | 11.23 |
Dll1 |
delta like canonical Notch ligand 1 |
358 |
0.85 |
chr13_34131726_34132056 | 11.06 |
Tubb2b |
tubulin, beta 2B class IIB |
1425 |
0.24 |
chr2_33215438_33216087 | 10.88 |
Angptl2 |
angiopoietin-like 2 |
307 |
0.87 |
chr5_91875962_91876131 | 10.79 |
Gm43688 |
predicted gene 43688 |
37357 |
0.11 |
chr8_12947304_12948554 | 10.77 |
Mcf2l |
mcf.2 transforming sequence-like |
10 |
0.49 |
chr5_146713132_146713362 | 10.51 |
4930573C15Rik |
RIKEN cDNA 4930573C15 gene |
6625 |
0.19 |
chr7_37439583_37439757 | 10.47 |
Gm44806 |
predicted gene 44806 |
27752 |
0.18 |
chr9_41889978_41890642 | 10.34 |
Gm40513 |
predicted gene, 40513 |
294 |
0.89 |
chr4_58943371_58943812 | 10.32 |
Zkscan16 |
zinc finger with KRAB and SCAN domains 16 |
37 |
0.97 |
chr4_97418604_97418964 | 10.26 |
Gm12696 |
predicted gene 12696 |
103548 |
0.08 |
chrX_143543266_143543620 | 10.18 |
Pak3 |
p21 (RAC1) activated kinase 3 |
24745 |
0.25 |
chr16_9281007_9281201 | 10.18 |
Gm49451 |
predicted gene, 49451 |
122334 |
0.06 |
chr10_26695225_26695646 | 10.02 |
Gm48893 |
predicted gene, 48893 |
139 |
0.96 |
chr14_12393556_12393971 | 9.94 |
Gm48267 |
predicted gene, 48267 |
8467 |
0.14 |
chr7_45639590_45639995 | 9.90 |
Mamstr |
MEF2 activating motif and SAP domain containing transcriptional regulator |
185 |
0.79 |
chr8_46470414_46471778 | 9.90 |
Acsl1 |
acyl-CoA synthetase long-chain family member 1 |
24 |
0.97 |
chr6_55676658_55677265 | 9.89 |
Neurod6 |
neurogenic differentiation 6 |
4302 |
0.26 |
chr12_72069940_72071249 | 9.89 |
Gpr135 |
G protein-coupled receptor 135 |
531 |
0.72 |
chr3_109782232_109782939 | 9.82 |
Ntng1 |
netrin G1 |
50674 |
0.16 |
chr13_12312047_12312406 | 9.79 |
Actn2 |
actinin alpha 2 |
28498 |
0.14 |
chr3_20776476_20776661 | 9.74 |
Gm18491 |
predicted gene, 18491 |
7495 |
0.19 |
chr14_54912471_54913268 | 9.62 |
Slc22a17 |
solute carrier family 22 (organic cation transporter), member 17 |
21 |
0.93 |
chr14_118925359_118925599 | 9.54 |
Dzip1 |
DAZ interacting protein 1 |
19 |
0.97 |
chr14_18759105_18759257 | 9.52 |
Gm22499 |
predicted gene, 22499 |
54988 |
0.13 |
chr9_40268412_40269319 | 9.51 |
Scn3b |
sodium channel, voltage-gated, type III, beta |
352 |
0.82 |
chr1_3671269_3672324 | 9.47 |
Xkr4 |
X-linked Kx blood group related 4 |
298 |
0.89 |
chr3_82547921_82548417 | 9.40 |
Npy2r |
neuropeptide Y receptor Y2 |
85 |
0.98 |
chr6_94773287_94774569 | 9.39 |
Gm43997 |
predicted gene, 43997 |
25504 |
0.15 |
chr2_106895457_106895666 | 9.34 |
Gm13901 |
predicted gene 13901 |
21210 |
0.17 |
chr3_94363621_94364486 | 9.24 |
C2cd4d |
C2 calcium-dependent domain containing 4D |
1550 |
0.16 |
chr18_83523941_83524284 | 9.23 |
Gm50416 |
predicted gene, 50416 |
1192 |
0.46 |
chr1_189187702_189188139 | 9.23 |
2900042K21Rik |
RIKEN cDNA 2900042K21 gene |
23093 |
0.18 |
chr4_134430506_134430992 | 9.22 |
1700021N21Rik |
RIKEN cDNA 1700021N21 gene |
19422 |
0.1 |
chr4_96697628_96698496 | 9.09 |
Cyp2j5 |
cytochrome P450, family 2, subfamily j, polypeptide 5 |
33908 |
0.19 |
chr3_63616179_63616468 | 8.98 |
Plch1 |
phospholipase C, eta 1 |
85720 |
0.08 |
chr1_72309841_72310010 | 8.95 |
Xrcc5 |
X-ray repair complementing defective repair in Chinese hamster cells 5 |
2498 |
0.23 |
chr9_8900765_8902148 | 8.89 |
Pgr |
progesterone receptor |
988 |
0.68 |
chr5_37162967_37163149 | 8.84 |
Gm1043 |
predicted gene 1043 |
209 |
0.94 |
chr6_88981517_88981873 | 8.82 |
4933427D06Rik |
RIKEN cDNA 4933427D06 gene |
31012 |
0.14 |
chr4_103325280_103325444 | 8.73 |
Oma1 |
OMA1 zinc metallopeptidase |
878 |
0.58 |
chr12_16643779_16644298 | 8.68 |
Lpin1 |
lipin 1 |
2928 |
0.23 |
chr4_141312456_141313176 | 8.64 |
Epha2 |
Eph receptor A2 |
3922 |
0.13 |
chr14_14350947_14351733 | 8.53 |
Il3ra |
interleukin 3 receptor, alpha chain |
1719 |
0.23 |
chr13_59011549_59011989 | 8.53 |
Gm34245 |
predicted gene, 34245 |
66527 |
0.09 |
chrX_143518439_143518663 | 8.44 |
Pak3 |
p21 (RAC1) activated kinase 3 |
40 |
0.99 |
chr18_60065037_60065286 | 8.42 |
Gm23576 |
predicted gene, 23576 |
109156 |
0.06 |
chr10_3863520_3864007 | 8.37 |
Gm16149 |
predicted gene 16149 |
5844 |
0.21 |
chr5_30920760_30922186 | 8.35 |
Khk |
ketohexokinase |
42 |
0.93 |
chr17_48999548_48999943 | 8.34 |
Lrfn2 |
leucine rich repeat and fibronectin type III domain containing 2 |
67366 |
0.11 |
chr15_78181729_78182061 | 8.29 |
Gm49694 |
predicted gene, 49694 |
7434 |
0.14 |
chr1_6733683_6734408 | 8.28 |
St18 |
suppression of tumorigenicity 18 |
825 |
0.73 |
chr10_13714527_13714874 | 8.28 |
Gm48773 |
predicted gene, 48773 |
87502 |
0.08 |
chr16_67620882_67621511 | 8.26 |
Cadm2 |
cell adhesion molecule 2 |
288 |
0.94 |
chr5_120195065_120195267 | 8.26 |
Rbm19 |
RNA binding motif protein 19 |
19441 |
0.18 |
chr16_85899316_85900502 | 8.25 |
Adamts5 |
a disintegrin-like and metallopeptidase (reprolysin type) with thrombospondin type 1 motif, 5 (aggrecanase-2) |
1919 |
0.44 |
chrX_170735840_170737140 | 8.23 |
Gm15069 |
predicted gene 15069 |
10717 |
0.28 |
chr13_116309603_116310279 | 8.18 |
Isl1 |
ISL1 transcription factor, LIM/homeodomain |
252 |
0.94 |
chr14_55520440_55521261 | 8.17 |
Nrl |
neural retina leucine zipper gene |
417 |
0.62 |
chr16_33605736_33606716 | 8.16 |
Slc12a8 |
solute carrier family 12 (potassium/chloride transporters), member 8 |
9599 |
0.26 |
chr6_107529484_107530270 | 8.16 |
Lrrn1 |
leucine rich repeat protein 1, neuronal |
109 |
0.97 |
chr16_42575508_42575977 | 8.12 |
Gm49739 |
predicted gene, 49739 |
88184 |
0.1 |
chr1_42703489_42704501 | 8.11 |
Pantr2 |
POU domain, class 3, transcription factor 3 adjacent noncoding transcript 2 |
4057 |
0.16 |
chr10_36507139_36507637 | 8.11 |
Hs3st5 |
heparan sulfate (glucosamine) 3-O-sulfotransferase 5 |
19 |
0.99 |
chr15_71727617_71728041 | 8.10 |
Fam135b |
family with sequence similarity 135, member B |
9 |
0.98 |
chr2_34107702_34107910 | 8.09 |
C230014O12Rik |
RIKEN cDNA C230014O12 gene |
71 |
0.98 |
chr16_81285322_81285497 | 8.08 |
Gm49555 |
predicted gene, 49555 |
4753 |
0.27 |
chr11_32000283_32000717 | 8.01 |
Nsg2 |
neuron specific gene family member 2 |
2 |
0.98 |
chr10_79613505_79614566 | 7.94 |
C2cd4c |
C2 calcium-dependent domain containing 4C |
10 |
0.95 |
chr4_23636552_23636896 | 7.92 |
Gm25978 |
predicted gene, 25978 |
9979 |
0.24 |
chr9_3532154_3533303 | 7.91 |
Gucy1a2 |
guanylate cyclase 1, soluble, alpha 2 |
50 |
0.98 |
chr11_32106427_32106633 | 7.91 |
Gm12108 |
predicted gene 12108 |
5302 |
0.22 |
chr1_41157746_41157964 | 7.90 |
4930448I06Rik |
RIKEN cDNA 4930448I06 gene |
23397 |
0.27 |
chr8_4492910_4494136 | 7.90 |
Cers4 |
ceramide synthase 4 |
2 |
0.97 |
chr3_121588840_121589464 | 7.90 |
A730020M07Rik |
RIKEN cDNA A730020M07 gene |
54215 |
0.09 |
chr10_39672573_39673015 | 7.87 |
Gm8899 |
predicted gene 8899 |
10705 |
0.13 |
chr2_38395315_38395504 | 7.86 |
Gm13589 |
predicted gene 13589 |
28593 |
0.12 |
chr4_117644839_117645519 | 7.82 |
Eri3 |
exoribonuclease 3 |
7841 |
0.16 |
chr17_27679167_27679824 | 7.81 |
Pacsin1 |
protein kinase C and casein kinase substrate in neurons 1 |
5686 |
0.12 |
chr12_70680124_70680305 | 7.80 |
Gm32369 |
predicted gene, 32369 |
1636 |
0.31 |
chr16_38924994_38925169 | 7.78 |
Gm22500 |
predicted gene, 22500 |
2128 |
0.33 |
chr2_136051705_136052005 | 7.78 |
Lamp5 |
lysosomal-associated membrane protein family, member 5 |
384 |
0.88 |
chr13_84059070_84059621 | 7.74 |
Gm17750 |
predicted gene, 17750 |
5427 |
0.24 |
chr5_107497460_107497812 | 7.70 |
Btbd8 |
BTB (POZ) domain containing 8 |
140 |
0.93 |
chr12_73241990_73242324 | 7.68 |
Trmt5 |
TRM5 tRNA methyltransferase 5 |
40514 |
0.14 |
chr4_81332537_81332688 | 7.67 |
Mpdz |
multiple PDZ domain protein |
429 |
0.87 |
chr1_119049949_119050658 | 7.66 |
Gli2 |
GLI-Kruppel family member GLI2 |
3036 |
0.28 |
chr4_120277239_120277533 | 7.64 |
Foxo6 |
forkhead box O6 |
9963 |
0.21 |
chr13_103096304_103096720 | 7.62 |
Mast4 |
microtubule associated serine/threonine kinase family member 4 |
316 |
0.94 |
chr7_125262700_125262978 | 7.60 |
Gm21957 |
predicted gene, 21957 |
42953 |
0.14 |
chr11_32057406_32057740 | 7.60 |
Gm12108 |
predicted gene 12108 |
43655 |
0.13 |
chr7_129664007_129664606 | 7.58 |
Gm33248 |
predicted gene, 33248 |
3099 |
0.26 |
chr4_81332888_81333223 | 7.57 |
Mpdz |
multiple PDZ domain protein |
14 |
0.98 |
chr13_34136680_34136848 | 7.57 |
Gm36500 |
predicted gene, 36500 |
2904 |
0.15 |
chr10_79681206_79682337 | 7.53 |
Cdc34 |
cell division cycle 34 |
424 |
0.63 |
chr1_38835547_38836894 | 7.52 |
Lonrf2 |
LON peptidase N-terminal domain and ring finger 2 |
154 |
0.95 |
chr1_14755119_14756069 | 7.51 |
Gm9947 |
predicted gene 9947 |
140 |
0.64 |
chr13_107663880_107664121 | 7.49 |
1700006H21Rik |
RIKEN cDNA 1700006H21 gene |
23397 |
0.19 |
chr3_127267961_127268143 | 7.48 |
Gm42972 |
predicted gene 42972 |
4237 |
0.16 |
chr1_56833380_56833600 | 7.45 |
Satb2 |
special AT-rich sequence binding protein 2 |
136350 |
0.04 |
chr1_37081753_37081984 | 7.45 |
Vwa3b |
von Willebrand factor A domain containing 3B |
18663 |
0.18 |
chrX_103533421_103533606 | 7.41 |
Gm9157 |
predicted gene 9157 |
4030 |
0.09 |
chr2_93199380_93200028 | 7.41 |
Trp53i11 |
transformation related protein 53 inducible protein 11 |
785 |
0.69 |
chr2_51753056_51753280 | 7.38 |
Gm13490 |
predicted gene 13490 |
21159 |
0.21 |
chr7_99312052_99312429 | 7.37 |
Gm45591 |
predicted gene 45591 |
8960 |
0.14 |
chr6_13835476_13835627 | 7.34 |
Gpr85 |
G protein-coupled receptor 85 |
1690 |
0.39 |
chr16_35564377_35564788 | 7.33 |
Gm5963 |
predicted pseudogene 5963 |
8974 |
0.18 |
chr2_180854741_180854913 | 7.30 |
Gm14339 |
predicted gene 14339 |
7175 |
0.11 |
chr1_194623663_194623996 | 7.29 |
Plxna2 |
plexin A2 |
4004 |
0.23 |
chr15_76461282_76462583 | 7.28 |
Scx |
scleraxis |
4412 |
0.09 |
chr15_93084965_93085116 | 7.27 |
Gm18685 |
predicted gene, 18685 |
4190 |
0.27 |
chr7_4119309_4120004 | 7.26 |
Ttyh1 |
tweety family member 1 |
34 |
0.91 |
chr4_8577454_8577829 | 7.26 |
Rab2a |
RAB2A, member RAS oncogene family |
41997 |
0.17 |
chr4_45184399_45185347 | 7.26 |
Frmpd1 |
FERM and PDZ domain containing 1 |
2 |
0.98 |
chr3_62603661_62604074 | 7.24 |
Gpr149 |
G protein-coupled receptor 149 |
1093 |
0.65 |
chr9_97019343_97019528 | 7.23 |
Spsb4 |
splA/ryanodine receptor domain and SOCS box containing 4 |
592 |
0.64 |
chr3_158561021_158562021 | 7.19 |
Lrrc7 |
leucine rich repeat containing 7 |
176 |
0.97 |
chr2_54435866_54436297 | 7.18 |
Galnt13 |
polypeptide N-acetylgalactosaminyltransferase 13 |
236 |
0.96 |
chr8_36142092_36142588 | 7.17 |
Gm38414 |
predicted gene, 38414 |
13670 |
0.15 |
chr12_31074463_31075268 | 7.15 |
Fam110c |
family with sequence similarity 110, member C |
1004 |
0.43 |
chr7_62046082_62046717 | 7.15 |
Mir344f |
microRNA Mir344f |
151 |
0.94 |
chr5_149527921_149528686 | 7.12 |
Wdr95 |
WD40 repeat domain 95 |
376 |
0.81 |
chr9_122571793_122572853 | 7.12 |
9530059O14Rik |
RIKEN cDNA 9530059O14 gene |
176 |
0.93 |
chr10_39427286_39427451 | 7.10 |
Gm6963 |
predicted gene 6963 |
2372 |
0.3 |
chr18_43687278_43687971 | 7.08 |
Jakmip2 |
janus kinase and microtubule interacting protein 2 |
1 |
0.98 |
chr9_83664968_83665283 | 7.08 |
Gm36120 |
predicted gene, 36120 |
22400 |
0.17 |
chr9_45608224_45608399 | 7.08 |
Gm22069 |
predicted gene, 22069 |
26501 |
0.18 |
chr1_155229862_155230191 | 7.06 |
BC034090 |
cDNA sequence BC034090 |
132 |
0.93 |
chr2_165563196_165563907 | 7.05 |
Eya2 |
EYA transcriptional coactivator and phosphatase 2 |
31481 |
0.13 |
chr6_77242597_77242788 | 7.05 |
Lrrtm1 |
leucine rich repeat transmembrane neuronal 1 |
3 |
0.99 |
chr14_14983885_14984321 | 7.05 |
Nek10 |
NIMA (never in mitosis gene a)- related kinase 10 |
53528 |
0.11 |
chr13_105256983_105257274 | 7.04 |
Rnf180 |
ring finger protein 180 |
13911 |
0.24 |
chr8_83049714_83049876 | 7.03 |
Gm45449 |
predicted gene 45449 |
37162 |
0.17 |
chr13_10360181_10360716 | 7.02 |
Chrm3 |
cholinergic receptor, muscarinic 3, cardiac |
115 |
0.97 |
chr8_83206069_83206220 | 7.02 |
Gm10645 |
predicted gene 10645 |
39974 |
0.12 |
chr17_93409383_93409594 | 7.00 |
Gm50001 |
predicted gene, 50001 |
17790 |
0.24 |
chr1_155233440_155234889 | 6.99 |
BC034090 |
cDNA sequence BC034090 |
1253 |
0.38 |
chr8_90069471_90069806 | 6.97 |
Tox3 |
TOX high mobility group box family member 3 |
278488 |
0.01 |
chr5_108549866_108550582 | 6.96 |
Cplx1 |
complexin 1 |
200 |
0.9 |
chrX_96713334_96713515 | 6.96 |
Gpr165 |
G protein-coupled receptor 165 |
17 |
0.99 |
chr3_109601173_109601348 | 6.95 |
Vav3 |
vav 3 oncogene |
27353 |
0.26 |
chr3_35340973_35341157 | 6.95 |
Gm25442 |
predicted gene, 25442 |
15451 |
0.23 |
chr9_23378360_23378672 | 6.94 |
Bmper |
BMP-binding endothelial regulator |
4584 |
0.36 |
chr10_45311684_45311835 | 6.94 |
Gm47433 |
predicted gene, 47433 |
13488 |
0.14 |
chr12_26635257_26635560 | 6.94 |
1700020D12Rik |
RIKEN cDNA 1700020D12 gene |
33099 |
0.18 |
chr3_107895270_107896682 | 6.94 |
Gstm5 |
glutathione S-transferase, mu 5 |
22 |
0.65 |
chr8_78635037_78635192 | 6.93 |
Gm2253 |
predicted gene 2253 |
30820 |
0.18 |
chr11_32220828_32222435 | 6.87 |
Rhbdf1 |
rhomboid 5 homolog 1 |
613 |
0.58 |
chr11_47641417_47641598 | 6.87 |
Sgcd |
sarcoglycan, delta (dystrophin-associated glycoprotein) |
4038 |
0.36 |
chr1_136142237_136142876 | 6.87 |
Kif21b |
kinesin family member 21B |
11102 |
0.11 |
chr8_45507619_45508001 | 6.83 |
Sorbs2 |
sorbin and SH3 domain containing 2 |
2 |
0.98 |
chr2_109960340_109960539 | 6.82 |
Lgr4 |
leucine-rich repeat-containing G protein-coupled receptor 4 |
15103 |
0.19 |
chr12_108333504_108334768 | 6.82 |
Cyp46a1 |
cytochrome P450, family 46, subfamily a, polypeptide 1 |
245 |
0.91 |
chr14_79916952_79917103 | 6.81 |
Gm49542 |
predicted gene, 49542 |
18560 |
0.15 |
chr13_72265859_72266010 | 6.78 |
Gm4052 |
predicted gene 4052 |
84287 |
0.09 |
chrX_162087416_162087768 | 6.77 |
Gm26317 |
predicted gene, 26317 |
18135 |
0.2 |
chr19_46523220_46524148 | 6.76 |
Trim8 |
tripartite motif-containing 8 |
9024 |
0.15 |
chr8_4210272_4211025 | 6.75 |
4932443L11Rik |
RIKEN cDNA 4932443L11 gene |
3766 |
0.1 |
chr1_170655683_170655862 | 6.75 |
Olfml2b |
olfactomedin-like 2B |
11240 |
0.18 |
chr14_47366959_47367257 | 6.72 |
Lgals3 |
lectin, galactose binding, soluble 3 |
643 |
0.58 |
chr9_71897497_71897698 | 6.71 |
Tcf12 |
transcription factor 12 |
1201 |
0.3 |
chrX_135796271_135796923 | 6.70 |
Gprasp1 |
G protein-coupled receptor associated sorting protein 1 |
991 |
0.31 |
chr2_55436835_55437680 | 6.69 |
Kcnj3 |
potassium inwardly-rectifying channel, subfamily J, member 3 |
92 |
0.98 |
chr5_15850216_15850406 | 6.68 |
Gm42453 |
predicted gene 42453 |
19936 |
0.14 |
chr3_46891172_46891323 | 6.65 |
Mir6379 |
microRNA 6379 |
9535 |
0.31 |
chr7_130692342_130693149 | 6.65 |
Tacc2 |
transforming, acidic coiled-coil containing protein 2 |
20 |
0.98 |
chr5_125111202_125111425 | 6.64 |
Ncor2 |
nuclear receptor co-repressor 2 |
13587 |
0.18 |
chr9_50722434_50722597 | 6.63 |
Dixdc1 |
DIX domain containing 1 |
5423 |
0.13 |
chr14_26118223_26119106 | 6.62 |
Duxbl2 |
double homeobox B-like 2 |
191 |
0.91 |
chr2_74426718_74427115 | 6.62 |
Lnpk |
lunapark, ER junction formation factor |
106190 |
0.05 |
chr2_180954073_180954615 | 6.61 |
Nkain4 |
Na+/K+ transporting ATPase interacting 4 |
25 |
0.6 |
chr7_76185076_76185361 | 6.59 |
Agbl1 |
ATP/GTP binding protein-like 1 |
44669 |
0.17 |
chr6_91284995_91285433 | 6.56 |
Fbln2 |
fibulin 2 |
19335 |
0.17 |
chr8_48458356_48458774 | 6.56 |
Tenm3 |
teneurin transmembrane protein 3 |
96748 |
0.08 |
chr7_79535477_79536145 | 6.55 |
Gm35040 |
predicted gene, 35040 |
232 |
0.85 |
chrX_102003725_102004324 | 6.54 |
Nhsl2 |
NHS-like 2 |
1020 |
0.5 |
chr19_61225302_61226760 | 6.54 |
Csf2ra |
colony stimulating factor 2 receptor, alpha, low-affinity (granulocyte-macrophage) |
541 |
0.67 |
chr12_28817164_28817549 | 6.52 |
Gm48905 |
predicted gene, 48905 |
7218 |
0.17 |
chr3_55587897_55588397 | 6.52 |
Gm43549 |
predicted gene 43549 |
5417 |
0.18 |
chr2_173257495_173258460 | 6.51 |
Pmepa1 |
prostate transmembrane protein, androgen induced 1 |
18212 |
0.17 |
chr16_28919525_28919676 | 6.49 |
Mb21d2 |
Mab-21 domain containing 2 |
10073 |
0.26 |
chr3_55226674_55226887 | 6.48 |
Dclk1 |
doublecortin-like kinase 1 |
15584 |
0.17 |
chr10_109011207_109011747 | 6.48 |
Syt1 |
synaptotagmin I |
495 |
0.87 |
chr12_3238767_3239202 | 6.47 |
Rab10os |
RAB10, member RAS oncogene family, opposite strand |
2373 |
0.24 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
6.8 | 20.3 | GO:0033693 | neurofilament bundle assembly(GO:0033693) |
5.1 | 15.4 | GO:1901843 | positive regulation of high voltage-gated calcium channel activity(GO:1901843) |
4.6 | 13.7 | GO:0097118 | neuroligin clustering involved in postsynaptic membrane assembly(GO:0097118) |
4.4 | 13.2 | GO:1902564 | negative regulation of neutrophil activation(GO:1902564) |
4.1 | 8.2 | GO:0048936 | peripheral nervous system neuron axonogenesis(GO:0048936) |
3.8 | 11.5 | GO:0021586 | pons maturation(GO:0021586) |
3.8 | 11.3 | GO:0032289 | central nervous system myelin formation(GO:0032289) |
3.6 | 14.4 | GO:0007386 | compartment pattern specification(GO:0007386) |
3.4 | 13.5 | GO:0071205 | protein localization to juxtaparanode region of axon(GO:0071205) |
3.2 | 12.9 | GO:0033563 | dorsal/ventral axon guidance(GO:0033563) |
2.9 | 5.8 | GO:0021776 | smoothened signaling pathway involved in ventral spinal cord interneuron specification(GO:0021775) smoothened signaling pathway involved in spinal cord motor neuron cell fate specification(GO:0021776) |
2.8 | 8.5 | GO:0072061 | inner medullary collecting duct development(GO:0072061) |
2.7 | 10.8 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
2.7 | 21.6 | GO:0046069 | cGMP catabolic process(GO:0046069) |
2.6 | 7.8 | GO:0003221 | right ventricular cardiac muscle tissue morphogenesis(GO:0003221) |
2.6 | 10.3 | GO:0046959 | habituation(GO:0046959) |
2.4 | 7.2 | GO:0035860 | glial cell-derived neurotrophic factor receptor signaling pathway(GO:0035860) |
2.4 | 4.7 | GO:0061205 | paramesonephric duct development(GO:0061205) |
2.3 | 4.6 | GO:0014734 | skeletal muscle hypertrophy(GO:0014734) |
2.3 | 6.9 | GO:1903690 | negative regulation of wound healing, spreading of epidermal cells(GO:1903690) |
2.3 | 6.9 | GO:0070649 | formin-nucleated actin cable assembly(GO:0070649) |
2.2 | 6.6 | GO:0003358 | noradrenergic neuron development(GO:0003358) |
2.2 | 21.8 | GO:0060013 | righting reflex(GO:0060013) |
2.2 | 6.5 | GO:0072137 | condensed mesenchymal cell proliferation(GO:0072137) |
2.2 | 13.0 | GO:0021631 | optic nerve morphogenesis(GO:0021631) |
2.2 | 6.5 | GO:0097155 | fasciculation of sensory neuron axon(GO:0097155) |
2.1 | 2.1 | GO:0003433 | chondrocyte development involved in endochondral bone morphogenesis(GO:0003433) |
2.1 | 6.3 | GO:0060478 | acrosomal vesicle exocytosis(GO:0060478) |
2.1 | 16.7 | GO:0090394 | negative regulation of excitatory postsynaptic potential(GO:0090394) |
2.1 | 4.1 | GO:2000969 | positive regulation of glutamate receptor signaling pathway(GO:1900451) positive regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000969) |
2.0 | 2.0 | GO:0071926 | cannabinoid signaling pathway(GO:0038171) endocannabinoid signaling pathway(GO:0071926) |
2.0 | 6.1 | GO:0038128 | ERBB2 signaling pathway(GO:0038128) |
2.0 | 6.0 | GO:0042628 | mating plug formation(GO:0042628) post-mating behavior(GO:0045297) |
2.0 | 5.9 | GO:0015772 | disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
2.0 | 13.8 | GO:0021942 | radial glia guided migration of Purkinje cell(GO:0021942) |
2.0 | 3.9 | GO:0003347 | epicardial cell to mesenchymal cell transition(GO:0003347) |
1.9 | 7.6 | GO:0060221 | retinal rod cell differentiation(GO:0060221) |
1.9 | 5.7 | GO:0060748 | tertiary branching involved in mammary gland duct morphogenesis(GO:0060748) |
1.9 | 13.1 | GO:0003025 | regulation of systemic arterial blood pressure by baroreceptor feedback(GO:0003025) |
1.9 | 5.6 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
1.8 | 11.0 | GO:0090273 | regulation of somatostatin secretion(GO:0090273) |
1.8 | 1.8 | GO:0010643 | cell communication by chemical coupling(GO:0010643) |
1.8 | 8.8 | GO:0097105 | presynaptic membrane assembly(GO:0097105) |
1.8 | 5.3 | GO:0007468 | regulation of rhodopsin gene expression(GO:0007468) |
1.7 | 1.7 | GO:0021550 | medulla oblongata development(GO:0021550) |
1.7 | 5.2 | GO:0035582 | sequestering of BMP in extracellular matrix(GO:0035582) |
1.7 | 6.9 | GO:2000821 | regulation of grooming behavior(GO:2000821) |
1.7 | 5.1 | GO:0050923 | regulation of negative chemotaxis(GO:0050923) |
1.6 | 8.2 | GO:2000324 | positive regulation of glucocorticoid receptor signaling pathway(GO:2000324) |
1.6 | 4.9 | GO:0048677 | axon extension involved in regeneration(GO:0048677) sprouting of injured axon(GO:0048682) |
1.6 | 4.8 | GO:0051902 | negative regulation of mitochondrial depolarization(GO:0051902) |
1.6 | 4.8 | GO:0042494 | detection of bacterial lipoprotein(GO:0042494) |
1.6 | 8.0 | GO:0014719 | skeletal muscle satellite cell activation(GO:0014719) |
1.6 | 4.8 | GO:1904219 | regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) regulation of serine C-palmitoyltransferase activity(GO:1904220) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
1.6 | 8.0 | GO:1904424 | regulation of GTP binding(GO:1904424) |
1.6 | 3.2 | GO:0060160 | negative regulation of dopamine receptor signaling pathway(GO:0060160) |
1.6 | 1.6 | GO:0060084 | synaptic transmission involved in micturition(GO:0060084) |
1.6 | 7.9 | GO:0060750 | epithelial cell proliferation involved in mammary gland duct elongation(GO:0060750) |
1.6 | 6.3 | GO:0060287 | epithelial cilium movement involved in determination of left/right asymmetry(GO:0060287) |
1.6 | 6.3 | GO:1901491 | negative regulation of lymphangiogenesis(GO:1901491) |
1.6 | 12.5 | GO:0060371 | regulation of atrial cardiac muscle cell membrane depolarization(GO:0060371) |
1.6 | 4.7 | GO:0072318 | clathrin coat disassembly(GO:0072318) |
1.6 | 6.2 | GO:0002051 | osteoblast fate commitment(GO:0002051) |
1.6 | 21.7 | GO:0031290 | retinal ganglion cell axon guidance(GO:0031290) |
1.5 | 4.6 | GO:0060060 | post-embryonic retina morphogenesis in camera-type eye(GO:0060060) |
1.5 | 4.6 | GO:0060178 | regulation of exocyst localization(GO:0060178) |
1.5 | 12.1 | GO:0014062 | regulation of serotonin secretion(GO:0014062) |
1.5 | 6.0 | GO:1903977 | positive regulation of glial cell migration(GO:1903977) |
1.5 | 6.0 | GO:0048681 | negative regulation of axon regeneration(GO:0048681) |
1.5 | 4.5 | GO:0035106 | operant conditioning(GO:0035106) |
1.5 | 7.4 | GO:0014054 | positive regulation of gamma-aminobutyric acid secretion(GO:0014054) |
1.5 | 4.5 | GO:0030167 | proteoglycan catabolic process(GO:0030167) |
1.5 | 8.9 | GO:0097151 | positive regulation of inhibitory postsynaptic potential(GO:0097151) modulation of inhibitory postsynaptic potential(GO:0098828) |
1.5 | 7.4 | GO:0007171 | activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
1.5 | 13.3 | GO:0010715 | regulation of extracellular matrix disassembly(GO:0010715) |
1.5 | 4.4 | GO:0060825 | fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:0060825) regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:2000313) |
1.5 | 4.4 | GO:0048162 | preantral ovarian follicle growth(GO:0001546) multi-layer follicle stage(GO:0048162) |
1.4 | 2.8 | GO:0070782 | phosphatidylserine exposure on apoptotic cell surface(GO:0070782) |
1.4 | 2.8 | GO:0070100 | negative regulation of chemokine-mediated signaling pathway(GO:0070100) |
1.4 | 5.6 | GO:0009448 | gamma-aminobutyric acid metabolic process(GO:0009448) |
1.4 | 4.2 | GO:0050717 | positive regulation of interleukin-1 alpha secretion(GO:0050717) |
1.4 | 6.9 | GO:0009912 | auditory receptor cell fate commitment(GO:0009912) inner ear receptor cell fate commitment(GO:0060120) |
1.4 | 5.5 | GO:0016576 | histone dephosphorylation(GO:0016576) |
1.4 | 9.7 | GO:0048743 | positive regulation of skeletal muscle fiber development(GO:0048743) |
1.4 | 4.1 | GO:0014012 | peripheral nervous system axon regeneration(GO:0014012) |
1.4 | 4.1 | GO:0014744 | positive regulation of muscle adaptation(GO:0014744) |
1.4 | 2.7 | GO:0035262 | gonad morphogenesis(GO:0035262) |
1.4 | 4.1 | GO:0097503 | sialylation(GO:0097503) |
1.4 | 2.7 | GO:0001661 | conditioned taste aversion(GO:0001661) |
1.3 | 5.4 | GO:0016560 | protein import into peroxisome matrix, docking(GO:0016560) |
1.3 | 2.7 | GO:0097374 | sensory neuron axon guidance(GO:0097374) |
1.3 | 4.0 | GO:0051410 | detoxification of nitrogen compound(GO:0051410) cellular detoxification of nitrogen compound(GO:0070458) |
1.3 | 4.0 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
1.3 | 3.9 | GO:0045113 | regulation of integrin biosynthetic process(GO:0045113) |
1.3 | 2.6 | GO:0097112 | gamma-aminobutyric acid receptor clustering(GO:0097112) |
1.3 | 5.3 | GO:0010637 | negative regulation of mitochondrial fusion(GO:0010637) |
1.3 | 3.9 | GO:0003219 | cardiac right ventricle formation(GO:0003219) |
1.3 | 3.8 | GO:0018364 | peptidyl-glutamine methylation(GO:0018364) |
1.3 | 6.3 | GO:0042483 | negative regulation of odontogenesis(GO:0042483) |
1.3 | 24.0 | GO:0035418 | protein localization to synapse(GO:0035418) |
1.2 | 3.7 | GO:0014707 | branchiomeric skeletal muscle development(GO:0014707) |
1.2 | 1.2 | GO:0051794 | regulation of catagen(GO:0051794) |
1.2 | 3.7 | GO:0003419 | growth plate cartilage chondrocyte proliferation(GO:0003419) |
1.2 | 12.3 | GO:0007216 | G-protein coupled glutamate receptor signaling pathway(GO:0007216) |
1.2 | 1.2 | GO:0010909 | regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010908) positive regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010909) positive regulation of proteoglycan biosynthetic process(GO:1902730) |
1.2 | 3.7 | GO:1901475 | pyruvate transmembrane transport(GO:1901475) |
1.2 | 4.8 | GO:0021853 | cerebral cortex GABAergic interneuron migration(GO:0021853) interneuron migration(GO:1904936) |
1.2 | 3.6 | GO:0015820 | branched-chain amino acid transport(GO:0015803) leucine transport(GO:0015820) |
1.2 | 16.5 | GO:0060384 | innervation(GO:0060384) |
1.2 | 3.5 | GO:0003357 | noradrenergic neuron differentiation(GO:0003357) |
1.2 | 9.4 | GO:0060004 | reflex(GO:0060004) |
1.2 | 2.3 | GO:0001757 | somite specification(GO:0001757) |
1.2 | 8.1 | GO:0048149 | behavioral response to ethanol(GO:0048149) |
1.2 | 12.7 | GO:0042711 | maternal behavior(GO:0042711) |
1.1 | 2.3 | GO:0007621 | negative regulation of female receptivity(GO:0007621) |
1.1 | 6.9 | GO:0021957 | corticospinal tract morphogenesis(GO:0021957) |
1.1 | 4.6 | GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
1.1 | 2.3 | GO:0035934 | corticosterone secretion(GO:0035934) regulation of corticosterone secretion(GO:2000852) |
1.1 | 4.6 | GO:0036072 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
1.1 | 2.3 | GO:0045200 | establishment or maintenance of neuroblast polarity(GO:0045196) establishment of neuroblast polarity(GO:0045200) |
1.1 | 6.8 | GO:0015884 | folic acid transport(GO:0015884) |
1.1 | 1.1 | GO:0072162 | metanephric mesenchymal cell differentiation(GO:0072162) |
1.1 | 3.4 | GO:0046532 | regulation of photoreceptor cell differentiation(GO:0046532) |
1.1 | 1.1 | GO:0014819 | regulation of skeletal muscle contraction(GO:0014819) |
1.1 | 3.4 | GO:0021882 | regulation of transcription from RNA polymerase II promoter involved in forebrain neuron fate commitment(GO:0021882) |
1.1 | 3.4 | GO:0071492 | cellular response to UV-A(GO:0071492) |
1.1 | 6.7 | GO:0007197 | adenylate cyclase-inhibiting G-protein coupled acetylcholine receptor signaling pathway(GO:0007197) phospholipase C-activating G-protein coupled acetylcholine receptor signaling pathway(GO:0007207) |
1.1 | 2.2 | GO:0032898 | neurotrophin production(GO:0032898) |
1.1 | 5.5 | GO:0048852 | diencephalon morphogenesis(GO:0048852) |
1.1 | 3.3 | GO:1903279 | regulation of calcium:sodium antiporter activity(GO:1903279) |
1.1 | 18.6 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
1.1 | 6.5 | GO:0071625 | vocalization behavior(GO:0071625) |
1.1 | 6.5 | GO:0071670 | smooth muscle cell chemotaxis(GO:0071670) |
1.1 | 7.6 | GO:0045199 | maintenance of epithelial cell apical/basal polarity(GO:0045199) |
1.1 | 3.2 | GO:0032377 | regulation of intracellular lipid transport(GO:0032377) regulation of intracellular sterol transport(GO:0032380) regulation of intracellular cholesterol transport(GO:0032383) |
1.1 | 1.1 | GO:2000698 | positive regulation of epithelial cell differentiation involved in kidney development(GO:2000698) |
1.1 | 16.1 | GO:0090103 | cochlea morphogenesis(GO:0090103) |
1.1 | 1.1 | GO:2001012 | mesenchymal cell differentiation involved in kidney development(GO:0072161) mesenchymal cell differentiation involved in renal system development(GO:2001012) |
1.1 | 7.5 | GO:0042118 | endothelial cell activation(GO:0042118) |
1.1 | 5.3 | GO:0016198 | axon choice point recognition(GO:0016198) |
1.1 | 4.2 | GO:0071947 | protein deubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0071947) |
1.1 | 4.2 | GO:0021871 | forebrain regionalization(GO:0021871) |
1.1 | 4.2 | GO:0007258 | JUN phosphorylation(GO:0007258) |
1.0 | 2.1 | GO:0072240 | distal convoluted tubule development(GO:0072025) DCT cell differentiation(GO:0072069) metanephric distal convoluted tubule development(GO:0072221) metanephric distal tubule development(GO:0072235) metanephric DCT cell differentiation(GO:0072240) |
1.0 | 7.3 | GO:0008038 | neuron recognition(GO:0008038) |
1.0 | 4.2 | GO:2001023 | regulation of response to drug(GO:2001023) |
1.0 | 4.2 | GO:0038031 | non-canonical Wnt signaling pathway via JNK cascade(GO:0038031) |
1.0 | 3.1 | GO:2001016 | positive regulation of skeletal muscle cell differentiation(GO:2001016) |
1.0 | 3.1 | GO:0060584 | regulation of prostaglandin-endoperoxide synthase activity(GO:0060584) positive regulation of prostaglandin-endoperoxide synthase activity(GO:0060585) |
1.0 | 1.0 | GO:0014053 | negative regulation of gamma-aminobutyric acid secretion(GO:0014053) |
1.0 | 2.1 | GO:2000211 | regulation of glutamate metabolic process(GO:2000211) |
1.0 | 2.1 | GO:0021773 | striatal medium spiny neuron differentiation(GO:0021773) |
1.0 | 4.1 | GO:1902261 | positive regulation of delayed rectifier potassium channel activity(GO:1902261) positive regulation of voltage-gated potassium channel activity(GO:1903818) |
1.0 | 2.1 | GO:0060024 | rhythmic synaptic transmission(GO:0060024) |
1.0 | 9.2 | GO:0095500 | acetylcholine receptor signaling pathway(GO:0095500) postsynaptic signal transduction(GO:0098926) signal transduction involved in cellular response to ammonium ion(GO:1903831) response to acetylcholine(GO:1905144) cellular response to acetylcholine(GO:1905145) |
1.0 | 8.1 | GO:0031536 | positive regulation of exit from mitosis(GO:0031536) |
1.0 | 6.1 | GO:1900028 | negative regulation of ruffle assembly(GO:1900028) |
1.0 | 5.0 | GO:0097264 | self proteolysis(GO:0097264) |
1.0 | 2.0 | GO:0014738 | regulation of muscle hyperplasia(GO:0014738) muscle hyperplasia(GO:0014900) |
1.0 | 16.1 | GO:0045956 | positive regulation of calcium ion-dependent exocytosis(GO:0045956) |
1.0 | 5.0 | GO:0033211 | adiponectin-activated signaling pathway(GO:0033211) |
1.0 | 2.0 | GO:0021530 | spinal cord oligodendrocyte cell differentiation(GO:0021529) spinal cord oligodendrocyte cell fate specification(GO:0021530) |
1.0 | 4.0 | GO:0022038 | corpus callosum development(GO:0022038) |
1.0 | 5.0 | GO:0035641 | locomotory exploration behavior(GO:0035641) |
1.0 | 1.0 | GO:0033058 | directional locomotion(GO:0033058) |
1.0 | 2.0 | GO:0070777 | D-aspartate transport(GO:0070777) D-aspartate import(GO:0070779) |
1.0 | 8.9 | GO:0022027 | interkinetic nuclear migration(GO:0022027) |
1.0 | 2.9 | GO:0014816 | skeletal muscle satellite cell differentiation(GO:0014816) |
1.0 | 2.9 | GO:0098902 | regulation of membrane depolarization during action potential(GO:0098902) |
1.0 | 2.9 | GO:0072385 | minus-end-directed organelle transport along microtubule(GO:0072385) |
1.0 | 2.9 | GO:2000327 | regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000325) positive regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000327) |
1.0 | 2.9 | GO:0046103 | inosine biosynthetic process(GO:0046103) |
1.0 | 4.8 | GO:0061339 | establishment of monopolar cell polarity(GO:0061162) establishment or maintenance of monopolar cell polarity(GO:0061339) |
1.0 | 1.0 | GO:0086028 | bundle of His cell to Purkinje myocyte signaling(GO:0086028) bundle of His cell action potential(GO:0086043) |
0.9 | 2.8 | GO:0030070 | insulin processing(GO:0030070) |
0.9 | 2.8 | GO:0048935 | peripheral nervous system neuron differentiation(GO:0048934) peripheral nervous system neuron development(GO:0048935) |
0.9 | 6.5 | GO:2000035 | regulation of stem cell division(GO:2000035) |
0.9 | 3.7 | GO:0019478 | D-amino acid catabolic process(GO:0019478) |
0.9 | 3.7 | GO:0061743 | motor learning(GO:0061743) |
0.9 | 7.3 | GO:0045617 | negative regulation of keratinocyte differentiation(GO:0045617) |
0.9 | 4.6 | GO:1902308 | regulation of peptidyl-serine dephosphorylation(GO:1902308) |
0.9 | 6.4 | GO:0021521 | ventral spinal cord interneuron specification(GO:0021521) cell fate specification involved in pattern specification(GO:0060573) |
0.9 | 0.9 | GO:0046684 | response to pyrethroid(GO:0046684) |
0.9 | 5.5 | GO:0010739 | positive regulation of protein kinase A signaling(GO:0010739) |
0.9 | 4.5 | GO:0060923 | cardiac muscle cell fate commitment(GO:0060923) |
0.9 | 1.8 | GO:0098903 | regulation of membrane repolarization during action potential(GO:0098903) |
0.9 | 0.9 | GO:0061577 | calcium ion transmembrane transport via high voltage-gated calcium channel(GO:0061577) |
0.9 | 0.9 | GO:0097113 | AMPA glutamate receptor clustering(GO:0097113) glutamate receptor clustering(GO:0097688) |
0.9 | 1.8 | GO:0072092 | ureteric bud invasion(GO:0072092) |
0.9 | 3.6 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
0.9 | 2.7 | GO:0001927 | exocyst assembly(GO:0001927) |
0.9 | 2.7 | GO:0061153 | trachea submucosa development(GO:0061152) trachea gland development(GO:0061153) |
0.9 | 1.8 | GO:1903261 | regulation of serine phosphorylation of STAT3 protein(GO:1903261) |
0.9 | 5.3 | GO:1901678 | iron coordination entity transport(GO:1901678) |
0.9 | 1.7 | GO:0021698 | cerebellar cortex structural organization(GO:0021698) |
0.9 | 0.9 | GO:0097475 | motor neuron migration(GO:0097475) spinal cord motor neuron migration(GO:0097476) |
0.9 | 7.8 | GO:0060292 | long term synaptic depression(GO:0060292) |
0.9 | 2.6 | GO:0061502 | early endosome to recycling endosome transport(GO:0061502) |
0.9 | 1.7 | GO:2000680 | regulation of rubidium ion transport(GO:2000680) |
0.9 | 3.4 | GO:0018406 | protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
0.9 | 4.3 | GO:0021795 | cerebral cortex cell migration(GO:0021795) |
0.9 | 1.7 | GO:0014045 | establishment of endothelial blood-brain barrier(GO:0014045) |
0.8 | 0.8 | GO:0031943 | regulation of glucocorticoid metabolic process(GO:0031943) |
0.8 | 1.7 | GO:0010728 | regulation of hydrogen peroxide biosynthetic process(GO:0010728) |
0.8 | 8.4 | GO:0010763 | positive regulation of fibroblast migration(GO:0010763) |
0.8 | 5.0 | GO:1900452 | regulation of long term synaptic depression(GO:1900452) |
0.8 | 1.7 | GO:0002314 | germinal center B cell differentiation(GO:0002314) |
0.8 | 3.3 | GO:0007442 | hindgut morphogenesis(GO:0007442) |
0.8 | 1.7 | GO:0055005 | ventricular cardiac myofibril assembly(GO:0055005) |
0.8 | 5.0 | GO:0042473 | outer ear morphogenesis(GO:0042473) |
0.8 | 2.5 | GO:0001998 | angiotensin mediated vasoconstriction involved in regulation of systemic arterial blood pressure(GO:0001998) |
0.8 | 1.6 | GO:0061356 | Wnt protein secretion(GO:0061355) regulation of Wnt protein secretion(GO:0061356) |
0.8 | 6.6 | GO:0036120 | cellular response to platelet-derived growth factor stimulus(GO:0036120) |
0.8 | 2.5 | GO:0045218 | zonula adherens maintenance(GO:0045218) |
0.8 | 2.5 | GO:0051182 | coenzyme transport(GO:0051182) |
0.8 | 0.8 | GO:0055009 | atrial cardiac muscle tissue development(GO:0003228) atrial cardiac muscle tissue morphogenesis(GO:0055009) |
0.8 | 0.8 | GO:0048148 | behavioral response to cocaine(GO:0048148) |
0.8 | 1.6 | GO:0045964 | positive regulation of catecholamine metabolic process(GO:0045915) positive regulation of dopamine metabolic process(GO:0045964) |
0.8 | 2.4 | GO:1904378 | maintenance of unfolded protein(GO:0036506) maintenance of unfolded protein involved in ERAD pathway(GO:1904378) |
0.8 | 9.7 | GO:0016486 | peptide hormone processing(GO:0016486) |
0.8 | 4.1 | GO:0032224 | positive regulation of synaptic transmission, cholinergic(GO:0032224) |
0.8 | 4.0 | GO:0032304 | negative regulation of icosanoid secretion(GO:0032304) |
0.8 | 1.6 | GO:0072107 | regulation of ureteric bud formation(GO:0072106) positive regulation of ureteric bud formation(GO:0072107) |
0.8 | 21.2 | GO:0043268 | positive regulation of potassium ion transport(GO:0043268) |
0.8 | 0.8 | GO:0003199 | endocardial cushion to mesenchymal transition involved in heart valve formation(GO:0003199) endocardial cushion to mesenchymal transition(GO:0090500) |
0.8 | 3.1 | GO:0031339 | negative regulation of vesicle fusion(GO:0031339) |
0.8 | 3.9 | GO:0060134 | prepulse inhibition(GO:0060134) |
0.8 | 0.8 | GO:0046864 | retinol transport(GO:0034633) isoprenoid transport(GO:0046864) terpenoid transport(GO:0046865) |
0.8 | 11.5 | GO:0030322 | stabilization of membrane potential(GO:0030322) |
0.8 | 1.5 | GO:0010735 | positive regulation of transcription via serum response element binding(GO:0010735) |
0.8 | 2.3 | GO:0061625 | fructose catabolic process(GO:0006001) fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate(GO:0061624) glycolytic process through fructose-1-phosphate(GO:0061625) |
0.8 | 0.8 | GO:0031443 | fast-twitch skeletal muscle fiber contraction(GO:0031443) |
0.8 | 1.5 | GO:0035434 | copper ion transmembrane transport(GO:0035434) |
0.8 | 55.8 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
0.8 | 7.5 | GO:0060081 | membrane hyperpolarization(GO:0060081) |
0.8 | 3.0 | GO:2000065 | negative regulation of aldosterone metabolic process(GO:0032345) negative regulation of aldosterone biosynthetic process(GO:0032348) negative regulation of cortisol biosynthetic process(GO:2000065) |
0.7 | 0.7 | GO:0021524 | visceral motor neuron differentiation(GO:0021524) |
0.7 | 6.0 | GO:1990118 | sodium ion import(GO:0097369) sodium ion import across plasma membrane(GO:0098719) sodium ion import into cell(GO:1990118) |
0.7 | 7.4 | GO:0021952 | central nervous system projection neuron axonogenesis(GO:0021952) |
0.7 | 1.5 | GO:0035694 | mitochondrial protein catabolic process(GO:0035694) |
0.7 | 0.7 | GO:0072048 | pattern specification involved in kidney development(GO:0061004) renal system pattern specification(GO:0072048) |
0.7 | 8.0 | GO:0003417 | growth plate cartilage development(GO:0003417) |
0.7 | 10.1 | GO:0045197 | establishment or maintenance of epithelial cell apical/basal polarity(GO:0045197) |
0.7 | 7.2 | GO:0009312 | oligosaccharide biosynthetic process(GO:0009312) |
0.7 | 2.2 | GO:0019747 | regulation of isoprenoid metabolic process(GO:0019747) |
0.7 | 1.4 | GO:0035993 | deltoid tuberosity development(GO:0035993) |
0.7 | 2.1 | GO:0034650 | cortisol metabolic process(GO:0034650) |
0.7 | 1.4 | GO:0098528 | skeletal muscle fiber differentiation(GO:0098528) |
0.7 | 2.8 | GO:0060414 | aorta smooth muscle tissue morphogenesis(GO:0060414) |
0.7 | 2.1 | GO:0030327 | prenylated protein catabolic process(GO:0030327) |
0.7 | 2.1 | GO:1904430 | negative regulation of t-circle formation(GO:1904430) |
0.7 | 2.8 | GO:1990035 | calcium ion import into cell(GO:1990035) |
0.7 | 4.9 | GO:0099515 | actin filament-based transport(GO:0099515) |
0.7 | 1.4 | GO:2000546 | positive regulation of cell chemotaxis to fibroblast growth factor(GO:1904849) positive regulation of endothelial cell chemotaxis to fibroblast growth factor(GO:2000546) |
0.7 | 2.1 | GO:0070141 | response to UV-A(GO:0070141) |
0.7 | 1.4 | GO:0002074 | extraocular skeletal muscle development(GO:0002074) |
0.7 | 1.4 | GO:0089700 | protein kinase D signaling(GO:0089700) |
0.7 | 2.1 | GO:0014870 | response to inactivity(GO:0014854) response to muscle inactivity(GO:0014870) response to muscle inactivity involved in regulation of muscle adaptation(GO:0014877) response to denervation involved in regulation of muscle adaptation(GO:0014894) |
0.7 | 4.8 | GO:0060973 | cell migration involved in heart development(GO:0060973) |
0.7 | 2.7 | GO:0019509 | L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
0.7 | 2.7 | GO:0048840 | otolith development(GO:0048840) |
0.7 | 12.7 | GO:0086010 | membrane depolarization during action potential(GO:0086010) |
0.7 | 2.0 | GO:0097011 | cellular response to granulocyte macrophage colony-stimulating factor stimulus(GO:0097011) |
0.7 | 3.3 | GO:1902459 | positive regulation of stem cell population maintenance(GO:1902459) |
0.7 | 2.7 | GO:2000980 | regulation of auditory receptor cell differentiation(GO:0045607) regulation of mechanoreceptor differentiation(GO:0045631) regulation of inner ear receptor cell differentiation(GO:2000980) |
0.7 | 7.3 | GO:2000311 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000311) |
0.7 | 2.0 | GO:0048669 | collateral sprouting in absence of injury(GO:0048669) |
0.7 | 3.9 | GO:0019262 | N-acetylneuraminate catabolic process(GO:0019262) |
0.7 | 0.7 | GO:0071321 | response to cGMP(GO:0070305) cellular response to cGMP(GO:0071321) |
0.7 | 1.3 | GO:0043490 | malate-aspartate shuttle(GO:0043490) |
0.7 | 4.6 | GO:0035881 | amacrine cell differentiation(GO:0035881) |
0.6 | 1.3 | GO:2000019 | negative regulation of male gonad development(GO:2000019) |
0.6 | 1.9 | GO:0051481 | negative regulation of cytosolic calcium ion concentration(GO:0051481) |
0.6 | 0.6 | GO:0061047 | foregut regionalization(GO:0060423) lung field specification(GO:0060424) lung induction(GO:0060492) positive regulation of branching involved in lung morphogenesis(GO:0061047) |
0.6 | 1.9 | GO:0051835 | positive regulation of synapse structural plasticity(GO:0051835) |
0.6 | 1.9 | GO:1901387 | positive regulation of voltage-gated calcium channel activity(GO:1901387) |
0.6 | 3.2 | GO:0045217 | cell-cell junction maintenance(GO:0045217) |
0.6 | 2.5 | GO:0003416 | endochondral bone growth(GO:0003416) |
0.6 | 1.3 | GO:0021843 | substrate-independent telencephalic tangential migration(GO:0021826) substrate-independent telencephalic tangential interneuron migration(GO:0021843) |
0.6 | 1.3 | GO:0060631 | regulation of meiosis I(GO:0060631) |
0.6 | 1.9 | GO:0090258 | negative regulation of mitochondrial fission(GO:0090258) |
0.6 | 6.8 | GO:0050962 | detection of light stimulus involved in visual perception(GO:0050908) detection of light stimulus involved in sensory perception(GO:0050962) |
0.6 | 7.4 | GO:0048268 | clathrin coat assembly(GO:0048268) |
0.6 | 0.6 | GO:0071415 | cellular response to caffeine(GO:0071313) cellular response to purine-containing compound(GO:0071415) |
0.6 | 5.0 | GO:0006044 | N-acetylglucosamine metabolic process(GO:0006044) |
0.6 | 1.2 | GO:0051586 | positive regulation of neurotransmitter uptake(GO:0051582) positive regulation of dopamine uptake involved in synaptic transmission(GO:0051586) positive regulation of catecholamine uptake involved in synaptic transmission(GO:0051944) |
0.6 | 1.2 | GO:0061055 | myotome development(GO:0061055) |
0.6 | 4.9 | GO:0042415 | norepinephrine metabolic process(GO:0042415) |
0.6 | 13.5 | GO:0010107 | potassium ion import(GO:0010107) |
0.6 | 4.2 | GO:0060272 | embryonic skeletal joint morphogenesis(GO:0060272) |
0.6 | 2.4 | GO:0030432 | peristalsis(GO:0030432) |
0.6 | 1.8 | GO:1903626 | positive regulation of apoptotic DNA fragmentation(GO:1902512) positive regulation of DNA catabolic process(GO:1903626) |
0.6 | 1.8 | GO:0060741 | prostate gland stromal morphogenesis(GO:0060741) |
0.6 | 1.8 | GO:0036092 | phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
0.6 | 2.4 | GO:0071847 | TNFSF11-mediated signaling pathway(GO:0071847) |
0.6 | 1.8 | GO:2000048 | negative regulation of cell-cell adhesion mediated by cadherin(GO:2000048) |
0.6 | 5.9 | GO:0030828 | positive regulation of cGMP biosynthetic process(GO:0030828) |
0.6 | 4.1 | GO:0001778 | plasma membrane repair(GO:0001778) |
0.6 | 0.6 | GO:2000507 | positive regulation of energy homeostasis(GO:2000507) |
0.6 | 1.7 | GO:0052203 | modulation of catalytic activity in other organism involved in symbiotic interaction(GO:0052203) modulation by host of symbiont catalytic activity(GO:0052422) |
0.6 | 1.1 | GO:0014042 | positive regulation of neuron maturation(GO:0014042) |
0.6 | 0.6 | GO:1900104 | hyaluranon cable assembly(GO:0036118) regulation of hyaluranon cable assembly(GO:1900104) positive regulation of hyaluranon cable assembly(GO:1900106) |
0.6 | 22.3 | GO:0051965 | positive regulation of synapse assembly(GO:0051965) |
0.6 | 1.1 | GO:0014724 | regulation of twitch skeletal muscle contraction(GO:0014724) |
0.6 | 0.6 | GO:0003340 | negative regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis(GO:0003340) |
0.6 | 2.3 | GO:0021798 | forebrain dorsal/ventral pattern formation(GO:0021798) |
0.6 | 1.1 | GO:0035992 | tendon cell differentiation(GO:0035990) tendon formation(GO:0035992) |
0.6 | 0.6 | GO:0021937 | cerebellar Purkinje cell-granule cell precursor cell signaling involved in regulation of granule cell precursor cell proliferation(GO:0021937) |
0.6 | 1.1 | GO:0001560 | regulation of cell growth by extracellular stimulus(GO:0001560) |
0.6 | 4.5 | GO:0001964 | startle response(GO:0001964) |
0.6 | 1.1 | GO:0060839 | endothelial cell fate commitment(GO:0060839) |
0.6 | 1.1 | GO:0009629 | response to gravity(GO:0009629) |
0.5 | 0.5 | GO:0034350 | regulation of glial cell apoptotic process(GO:0034350) |
0.5 | 2.2 | GO:0021984 | adenohypophysis development(GO:0021984) |
0.5 | 4.4 | GO:1902259 | regulation of delayed rectifier potassium channel activity(GO:1902259) |
0.5 | 27.2 | GO:0071805 | potassium ion transmembrane transport(GO:0071805) |
0.5 | 0.5 | GO:1902896 | terminal web assembly(GO:1902896) |
0.5 | 1.1 | GO:0038026 | reelin-mediated signaling pathway(GO:0038026) |
0.5 | 1.6 | GO:0035609 | C-terminal protein deglutamylation(GO:0035609) |
0.5 | 1.1 | GO:0030382 | sperm mitochondrion organization(GO:0030382) |
0.5 | 2.1 | GO:0042637 | catagen(GO:0042637) |
0.5 | 0.5 | GO:0021797 | forebrain anterior/posterior pattern specification(GO:0021797) |
0.5 | 0.5 | GO:0043465 | regulation of fermentation(GO:0043465) regulation of NAD metabolic process(GO:1902688) regulation of glucose catabolic process to lactate via pyruvate(GO:1904023) |
0.5 | 2.1 | GO:0070900 | mitochondrial tRNA modification(GO:0070900) mitochondrial RNA modification(GO:1900864) |
0.5 | 1.0 | GO:0031915 | positive regulation of synaptic plasticity(GO:0031915) |
0.5 | 1.5 | GO:0060179 | male mating behavior(GO:0060179) |
0.5 | 1.0 | GO:0061368 | behavioral response to chemical pain(GO:0061366) behavioral response to formalin induced pain(GO:0061368) |
0.5 | 0.5 | GO:1903116 | positive regulation of actin filament-based movement(GO:1903116) |
0.5 | 2.5 | GO:0033578 | protein glycosylation in Golgi(GO:0033578) |
0.5 | 5.0 | GO:0036065 | fucosylation(GO:0036065) |
0.5 | 1.0 | GO:1901420 | negative regulation of response to alcohol(GO:1901420) |
0.5 | 1.0 | GO:1903975 | regulation of glial cell migration(GO:1903975) |
0.5 | 5.0 | GO:0032957 | inositol trisphosphate metabolic process(GO:0032957) |
0.5 | 1.5 | GO:0002930 | trabecular meshwork development(GO:0002930) |
0.5 | 3.5 | GO:0055003 | cardiac myofibril assembly(GO:0055003) |
0.5 | 0.5 | GO:0090027 | negative regulation of monocyte chemotaxis(GO:0090027) |
0.5 | 1.0 | GO:1901656 | glycoside transport(GO:1901656) |
0.5 | 0.5 | GO:0014826 | vein smooth muscle contraction(GO:0014826) |
0.5 | 6.8 | GO:0003298 | physiological muscle hypertrophy(GO:0003298) physiological cardiac muscle hypertrophy(GO:0003301) cell growth involved in cardiac muscle cell development(GO:0061049) |
0.5 | 1.0 | GO:0072697 | protein localization to cell cortex(GO:0072697) |
0.5 | 0.5 | GO:0071694 | protein localization to extracellular region(GO:0071692) maintenance of protein location in extracellular region(GO:0071694) |
0.5 | 0.5 | GO:0016344 | meiotic chromosome movement towards spindle pole(GO:0016344) |
0.5 | 0.5 | GO:2001055 | positive regulation of mesenchymal cell apoptotic process(GO:2001055) |
0.5 | 4.7 | GO:0043949 | regulation of cAMP-mediated signaling(GO:0043949) |
0.5 | 1.4 | GO:2000503 | positive regulation of natural killer cell chemotaxis(GO:2000503) |
0.5 | 2.8 | GO:0060068 | vagina development(GO:0060068) |
0.5 | 2.8 | GO:2000009 | negative regulation of protein localization to cell surface(GO:2000009) |
0.5 | 1.9 | GO:0035902 | response to immobilization stress(GO:0035902) |
0.5 | 1.4 | GO:0042045 | epithelial fluid transport(GO:0042045) |
0.5 | 1.4 | GO:0016557 | peroxisome membrane biogenesis(GO:0016557) |
0.5 | 1.8 | GO:0033564 | anterior/posterior axon guidance(GO:0033564) |
0.5 | 0.5 | GO:1905005 | regulation of epithelial to mesenchymal transition involved in endocardial cushion formation(GO:1905005) |
0.5 | 2.3 | GO:0060467 | negative regulation of fertilization(GO:0060467) |
0.5 | 0.5 | GO:0008065 | establishment of blood-nerve barrier(GO:0008065) |
0.5 | 1.4 | GO:1903847 | regulation of aorta morphogenesis(GO:1903847) positive regulation of aorta morphogenesis(GO:1903849) |
0.4 | 2.2 | GO:0072321 | chaperone-mediated protein transport(GO:0072321) |
0.4 | 2.2 | GO:0046110 | xanthine catabolic process(GO:0009115) xanthine metabolic process(GO:0046110) |
0.4 | 2.2 | GO:0033227 | dsRNA transport(GO:0033227) |
0.4 | 0.4 | GO:0014735 | regulation of muscle atrophy(GO:0014735) |
0.4 | 1.8 | GO:0021869 | forebrain ventricular zone progenitor cell division(GO:0021869) |
0.4 | 0.9 | GO:0044034 | negative stranded viral RNA replication(GO:0039689) multi-organism biosynthetic process(GO:0044034) |
0.4 | 3.1 | GO:0050965 | detection of temperature stimulus involved in sensory perception(GO:0050961) detection of temperature stimulus involved in sensory perception of pain(GO:0050965) |
0.4 | 1.3 | GO:1904970 | brush border assembly(GO:1904970) |
0.4 | 0.9 | GO:0051660 | establishment of centrosome localization(GO:0051660) |
0.4 | 1.3 | GO:1902774 | late endosome to lysosome transport(GO:1902774) |
0.4 | 2.2 | GO:0040037 | negative regulation of fibroblast growth factor receptor signaling pathway(GO:0040037) |
0.4 | 0.4 | GO:0055059 | asymmetric neuroblast division(GO:0055059) |
0.4 | 1.3 | GO:0035754 | B cell chemotaxis(GO:0035754) |
0.4 | 1.3 | GO:0048014 | Tie signaling pathway(GO:0048014) |
0.4 | 1.3 | GO:0070093 | negative regulation of glucagon secretion(GO:0070093) |
0.4 | 0.4 | GO:0051365 | cellular response to potassium ion starvation(GO:0051365) |
0.4 | 0.4 | GO:0071500 | cellular response to nitrosative stress(GO:0071500) |
0.4 | 2.1 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
0.4 | 3.3 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
0.4 | 0.8 | GO:0051964 | negative regulation of synapse assembly(GO:0051964) |
0.4 | 1.6 | GO:0071420 | cellular response to histamine(GO:0071420) |
0.4 | 0.4 | GO:0003257 | positive regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation(GO:0003257) |
0.4 | 2.8 | GO:0051764 | actin crosslink formation(GO:0051764) |
0.4 | 1.2 | GO:0006842 | tricarboxylic acid transport(GO:0006842) citrate transport(GO:0015746) |
0.4 | 1.2 | GO:0036112 | medium-chain fatty-acyl-CoA metabolic process(GO:0036112) |
0.4 | 1.2 | GO:0090310 | negative regulation of methylation-dependent chromatin silencing(GO:0090310) |
0.4 | 0.8 | GO:0002727 | natural killer cell cytokine production(GO:0002370) regulation of natural killer cell cytokine production(GO:0002727) |
0.4 | 4.7 | GO:2001258 | negative regulation of cation channel activity(GO:2001258) |
0.4 | 2.0 | GO:0014824 | artery smooth muscle contraction(GO:0014824) |
0.4 | 1.2 | GO:0021983 | pituitary gland development(GO:0021983) |
0.4 | 0.4 | GO:0032344 | regulation of aldosterone metabolic process(GO:0032344) |
0.4 | 2.3 | GO:0043653 | mitochondrial fragmentation involved in apoptotic process(GO:0043653) |
0.4 | 2.7 | GO:0016127 | cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
0.4 | 1.9 | GO:0006642 | triglyceride mobilization(GO:0006642) |
0.4 | 1.6 | GO:0060080 | inhibitory postsynaptic potential(GO:0060080) |
0.4 | 0.4 | GO:0003150 | muscular septum morphogenesis(GO:0003150) |
0.4 | 1.2 | GO:0002386 | immune response in mucosal-associated lymphoid tissue(GO:0002386) |
0.4 | 0.8 | GO:0033326 | cerebrospinal fluid secretion(GO:0033326) |
0.4 | 3.5 | GO:0006983 | ER overload response(GO:0006983) |
0.4 | 0.8 | GO:0042487 | regulation of odontogenesis of dentin-containing tooth(GO:0042487) |
0.4 | 1.1 | GO:0038044 | transforming growth factor-beta secretion(GO:0038044) regulation of transforming growth factor-beta secretion(GO:2001201) |
0.4 | 1.1 | GO:0031117 | positive regulation of microtubule depolymerization(GO:0031117) |
0.4 | 3.0 | GO:0070863 | positive regulation of protein exit from endoplasmic reticulum(GO:0070863) |
0.4 | 1.1 | GO:0032485 | Ral protein signal transduction(GO:0032484) regulation of Ral protein signal transduction(GO:0032485) |
0.4 | 1.5 | GO:0086019 | cell-cell signaling involved in cardiac conduction(GO:0086019) |
0.4 | 0.7 | GO:0001831 | trophectodermal cellular morphogenesis(GO:0001831) |
0.4 | 1.1 | GO:1904948 | midbrain dopaminergic neuron differentiation(GO:1904948) |
0.4 | 1.9 | GO:1901858 | regulation of mitochondrial DNA metabolic process(GO:1901858) |
0.4 | 1.1 | GO:0016103 | diterpenoid catabolic process(GO:0016103) retinoic acid catabolic process(GO:0034653) |
0.4 | 0.7 | GO:0060648 | mammary gland bud morphogenesis(GO:0060648) |
0.4 | 0.7 | GO:0046098 | guanine metabolic process(GO:0046098) |
0.4 | 2.2 | GO:0016339 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
0.4 | 0.4 | GO:0060982 | coronary artery morphogenesis(GO:0060982) |
0.4 | 1.1 | GO:0061084 | regulation of protein refolding(GO:0061083) negative regulation of protein refolding(GO:0061084) |
0.4 | 0.4 | GO:0030035 | microspike assembly(GO:0030035) |
0.4 | 0.7 | GO:0016048 | detection of temperature stimulus(GO:0016048) |
0.4 | 0.7 | GO:0021764 | amygdala development(GO:0021764) |
0.4 | 1.1 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
0.4 | 0.4 | GO:0071865 | regulation of apoptotic process in bone marrow(GO:0071865) negative regulation of apoptotic process in bone marrow(GO:0071866) |
0.4 | 0.4 | GO:1900020 | regulation of protein kinase C activity(GO:1900019) positive regulation of protein kinase C activity(GO:1900020) |
0.4 | 1.1 | GO:0021571 | rhombomere 5 development(GO:0021571) |
0.3 | 2.1 | GO:0010457 | centriole-centriole cohesion(GO:0010457) |
0.3 | 0.7 | GO:0010519 | negative regulation of phospholipase activity(GO:0010519) |
0.3 | 0.7 | GO:0045714 | regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045714) |
0.3 | 0.7 | GO:0046668 | regulation of retinal cell programmed cell death(GO:0046668) |
0.3 | 1.4 | GO:0035385 | Roundabout signaling pathway(GO:0035385) |
0.3 | 1.0 | GO:0006177 | GMP biosynthetic process(GO:0006177) |
0.3 | 0.3 | GO:1902897 | regulation of postsynaptic density protein 95 clustering(GO:1902897) |
0.3 | 3.0 | GO:0043651 | linoleic acid metabolic process(GO:0043651) |
0.3 | 1.0 | GO:2000599 | regulation of cyclin catabolic process(GO:2000598) negative regulation of cyclin catabolic process(GO:2000599) |
0.3 | 2.3 | GO:0048630 | skeletal muscle tissue growth(GO:0048630) |
0.3 | 1.0 | GO:2000525 | regulation of T cell costimulation(GO:2000523) positive regulation of T cell costimulation(GO:2000525) |
0.3 | 0.7 | GO:0021520 | spinal cord motor neuron cell fate specification(GO:0021520) |
0.3 | 1.3 | GO:0070213 | protein auto-ADP-ribosylation(GO:0070213) |
0.3 | 1.0 | GO:0006566 | threonine metabolic process(GO:0006566) |
0.3 | 0.3 | GO:0072053 | renal inner medulla development(GO:0072053) |
0.3 | 0.6 | GO:0035021 | negative regulation of Rac protein signal transduction(GO:0035021) |
0.3 | 1.3 | GO:1903799 | negative regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903799) |
0.3 | 1.3 | GO:0010919 | regulation of inositol phosphate biosynthetic process(GO:0010919) |
0.3 | 0.3 | GO:0060161 | positive regulation of dopamine receptor signaling pathway(GO:0060161) |
0.3 | 0.3 | GO:1901187 | regulation of ephrin receptor signaling pathway(GO:1901187) |
0.3 | 0.9 | GO:0021936 | regulation of cerebellar granule cell precursor proliferation(GO:0021936) |
0.3 | 0.9 | GO:0021615 | glossopharyngeal nerve development(GO:0021563) glossopharyngeal nerve morphogenesis(GO:0021615) |
0.3 | 1.6 | GO:0048671 | negative regulation of collateral sprouting(GO:0048671) |
0.3 | 0.6 | GO:0009051 | pentose-phosphate shunt, oxidative branch(GO:0009051) |
0.3 | 1.6 | GO:0009235 | cobalamin metabolic process(GO:0009235) |
0.3 | 1.9 | GO:0006689 | ganglioside catabolic process(GO:0006689) |
0.3 | 9.2 | GO:0006813 | potassium ion transport(GO:0006813) |
0.3 | 0.9 | GO:0042427 | serotonin biosynthetic process(GO:0042427) primary amino compound biosynthetic process(GO:1901162) |
0.3 | 0.9 | GO:0032074 | negative regulation of nuclease activity(GO:0032074) |
0.3 | 1.8 | GO:1901223 | negative regulation of NIK/NF-kappaB signaling(GO:1901223) |
0.3 | 0.6 | GO:0045039 | protein import into mitochondrial inner membrane(GO:0045039) |
0.3 | 0.3 | GO:2000474 | regulation of opioid receptor signaling pathway(GO:2000474) |
0.3 | 4.2 | GO:0046621 | negative regulation of organ growth(GO:0046621) |
0.3 | 1.8 | GO:0071803 | positive regulation of podosome assembly(GO:0071803) |
0.3 | 2.4 | GO:0021884 | forebrain neuron development(GO:0021884) |
0.3 | 3.3 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
0.3 | 1.5 | GO:0042135 | neurotransmitter catabolic process(GO:0042135) |
0.3 | 0.3 | GO:0010835 | regulation of protein ADP-ribosylation(GO:0010835) |
0.3 | 0.6 | GO:0042360 | vitamin E metabolic process(GO:0042360) |
0.3 | 0.9 | GO:1900095 | regulation of dosage compensation by inactivation of X chromosome(GO:1900095) |
0.3 | 0.9 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) |
0.3 | 1.5 | GO:0035414 | negative regulation of catenin import into nucleus(GO:0035414) |
0.3 | 0.3 | GO:0003331 | regulation of extracellular matrix constituent secretion(GO:0003330) positive regulation of extracellular matrix constituent secretion(GO:0003331) |
0.3 | 1.4 | GO:0031000 | response to caffeine(GO:0031000) |
0.3 | 0.9 | GO:0050955 | thermoception(GO:0050955) |
0.3 | 1.7 | GO:0032048 | cardiolipin metabolic process(GO:0032048) |
0.3 | 2.6 | GO:0035428 | hexose transmembrane transport(GO:0035428) |
0.3 | 0.9 | GO:1900127 | positive regulation of hyaluronan biosynthetic process(GO:1900127) |
0.3 | 1.7 | GO:0015074 | DNA integration(GO:0015074) |
0.3 | 0.6 | GO:0072386 | plus-end-directed vesicle transport along microtubule(GO:0072383) plus-end-directed organelle transport along microtubule(GO:0072386) |
0.3 | 0.8 | GO:0033566 | gamma-tubulin complex localization(GO:0033566) |
0.3 | 1.7 | GO:0031340 | positive regulation of vesicle fusion(GO:0031340) |
0.3 | 1.7 | GO:0048251 | elastic fiber assembly(GO:0048251) |
0.3 | 0.8 | GO:1903265 | positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
0.3 | 0.3 | GO:0007195 | adenylate cyclase-inhibiting dopamine receptor signaling pathway(GO:0007195) |
0.3 | 0.5 | GO:0003406 | retinal pigment epithelium development(GO:0003406) |
0.3 | 1.1 | GO:0070197 | meiotic telomere tethering at nuclear periphery(GO:0044821) meiotic attachment of telomere to nuclear envelope(GO:0070197) chromosome attachment to the nuclear envelope(GO:0097240) |
0.3 | 1.1 | GO:0010544 | negative regulation of platelet activation(GO:0010544) |
0.3 | 4.5 | GO:0048305 | immunoglobulin secretion(GO:0048305) |
0.3 | 1.6 | GO:2000010 | positive regulation of protein localization to cell surface(GO:2000010) |
0.3 | 3.2 | GO:0060074 | synapse maturation(GO:0060074) |
0.3 | 3.4 | GO:0006415 | translational termination(GO:0006415) |
0.3 | 0.5 | GO:0035984 | response to trichostatin A(GO:0035983) cellular response to trichostatin A(GO:0035984) |
0.3 | 0.8 | GO:0046618 | drug export(GO:0046618) |
0.3 | 0.8 | GO:0001922 | B-1 B cell homeostasis(GO:0001922) |
0.3 | 0.5 | GO:0042249 | establishment of planar polarity of embryonic epithelium(GO:0042249) |
0.3 | 0.8 | GO:2000118 | regulation of sodium-dependent phosphate transport(GO:2000118) |
0.3 | 1.8 | GO:0021895 | cerebral cortex neuron differentiation(GO:0021895) |
0.3 | 0.3 | GO:0072174 | metanephric tubule formation(GO:0072174) |
0.3 | 2.8 | GO:0002523 | leukocyte migration involved in inflammatory response(GO:0002523) |
0.3 | 0.5 | GO:0035793 | positive regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway(GO:0035793) regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway(GO:1900238) positive regulation of metanephric mesenchymal cell migration(GO:2000591) |
0.3 | 0.5 | GO:0089711 | L-glutamate transmembrane transport(GO:0089711) |
0.3 | 0.8 | GO:0015867 | ATP transport(GO:0015867) |
0.3 | 1.3 | GO:0048715 | negative regulation of oligodendrocyte differentiation(GO:0048715) |
0.2 | 0.7 | GO:2001206 | positive regulation of osteoclast development(GO:2001206) |
0.2 | 0.5 | GO:1902498 | regulation of protein autoubiquitination(GO:1902498) |
0.2 | 0.5 | GO:1901873 | regulation of post-translational protein modification(GO:1901873) negative regulation of post-translational protein modification(GO:1901874) |
0.2 | 1.7 | GO:0043045 | DNA methylation involved in embryo development(GO:0043045) changes to DNA methylation involved in embryo development(GO:1901538) |
0.2 | 4.2 | GO:2001014 | regulation of skeletal muscle cell differentiation(GO:2001014) |
0.2 | 7.4 | GO:0008333 | endosome to lysosome transport(GO:0008333) |
0.2 | 3.2 | GO:0050650 | chondroitin sulfate proteoglycan biosynthetic process(GO:0050650) |
0.2 | 4.2 | GO:0007616 | long-term memory(GO:0007616) |
0.2 | 0.2 | GO:0021979 | hypothalamus cell differentiation(GO:0021979) |
0.2 | 7.0 | GO:0031424 | keratinization(GO:0031424) |
0.2 | 0.2 | GO:0071288 | cellular response to mercury ion(GO:0071288) |
0.2 | 1.0 | GO:0035822 | meiotic gene conversion(GO:0006311) gene conversion(GO:0035822) |
0.2 | 0.7 | GO:0032687 | negative regulation of interferon-alpha production(GO:0032687) |
0.2 | 0.7 | GO:1903899 | positive regulation of PERK-mediated unfolded protein response(GO:1903899) |
0.2 | 0.5 | GO:1902805 | positive regulation of synaptic vesicle transport(GO:1902805) |
0.2 | 1.7 | GO:0070170 | regulation of tooth mineralization(GO:0070170) |
0.2 | 0.7 | GO:0006553 | lysine metabolic process(GO:0006553) |
0.2 | 0.2 | GO:0034146 | toll-like receptor 5 signaling pathway(GO:0034146) |
0.2 | 0.9 | GO:0006742 | NADP catabolic process(GO:0006742) |
0.2 | 0.2 | GO:0007354 | zygotic determination of anterior/posterior axis, embryo(GO:0007354) |
0.2 | 2.3 | GO:0035510 | DNA dealkylation(GO:0035510) |
0.2 | 0.7 | GO:0003105 | negative regulation of glomerular filtration(GO:0003105) |
0.2 | 0.7 | GO:0002331 | pre-B cell allelic exclusion(GO:0002331) |
0.2 | 0.5 | GO:0044341 | sodium-dependent phosphate transport(GO:0044341) |
0.2 | 0.7 | GO:0007084 | mitotic nuclear envelope reassembly(GO:0007084) |
0.2 | 1.4 | GO:0048539 | bone marrow development(GO:0048539) |
0.2 | 0.7 | GO:0043615 | astrocyte cell migration(GO:0043615) |
0.2 | 0.5 | GO:0060700 | regulation of ribonuclease activity(GO:0060700) |
0.2 | 0.2 | GO:0032829 | regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0032829) |
0.2 | 0.7 | GO:0070314 | G1 to G0 transition(GO:0070314) |
0.2 | 0.4 | GO:0090071 | negative regulation of ribosome biogenesis(GO:0090071) |
0.2 | 0.4 | GO:0007089 | traversing start control point of mitotic cell cycle(GO:0007089) |
0.2 | 1.1 | GO:0043987 | histone H3-S10 phosphorylation(GO:0043987) |
0.2 | 0.2 | GO:0070212 | protein poly-ADP-ribosylation(GO:0070212) |
0.2 | 0.2 | GO:0048818 | positive regulation of hair follicle maturation(GO:0048818) |
0.2 | 2.2 | GO:0009954 | proximal/distal pattern formation(GO:0009954) |
0.2 | 0.7 | GO:0090214 | spongiotrophoblast layer developmental growth(GO:0090214) |
0.2 | 6.0 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
0.2 | 2.7 | GO:0007271 | synaptic transmission, cholinergic(GO:0007271) |
0.2 | 0.6 | GO:0010986 | positive regulation of lipoprotein particle clearance(GO:0010986) |
0.2 | 1.0 | GO:0031145 | anaphase-promoting complex-dependent catabolic process(GO:0031145) |
0.2 | 2.8 | GO:0048026 | positive regulation of mRNA splicing, via spliceosome(GO:0048026) |
0.2 | 0.2 | GO:0070571 | negative regulation of neuron projection regeneration(GO:0070571) |
0.2 | 12.8 | GO:0001764 | neuron migration(GO:0001764) |
0.2 | 2.8 | GO:0001937 | negative regulation of endothelial cell proliferation(GO:0001937) |
0.2 | 0.6 | GO:0003214 | cardiac left ventricle morphogenesis(GO:0003214) |
0.2 | 0.4 | GO:0015860 | purine nucleoside transmembrane transport(GO:0015860) purine-containing compound transmembrane transport(GO:0072530) nucleoside transmembrane transport(GO:1901642) |
0.2 | 0.4 | GO:0048664 | neuron fate determination(GO:0048664) |
0.2 | 0.6 | GO:1990928 | response to amino acid starvation(GO:1990928) |
0.2 | 0.2 | GO:0042661 | regulation of mesodermal cell fate specification(GO:0042661) |
0.2 | 0.4 | GO:0002175 | protein localization to paranode region of axon(GO:0002175) |
0.2 | 0.2 | GO:0033092 | positive regulation of immature T cell proliferation in thymus(GO:0033092) |
0.2 | 2.3 | GO:0007215 | glutamate receptor signaling pathway(GO:0007215) |
0.2 | 0.4 | GO:0060665 | regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling(GO:0060665) |
0.2 | 0.4 | GO:0071372 | cellular response to follicle-stimulating hormone stimulus(GO:0071372) |
0.2 | 0.4 | GO:0071257 | cellular response to electrical stimulus(GO:0071257) |
0.2 | 3.2 | GO:0042538 | hyperosmotic salinity response(GO:0042538) |
0.2 | 0.6 | GO:1903232 | melanosome assembly(GO:1903232) |
0.2 | 0.6 | GO:0090383 | phagosome acidification(GO:0090383) |
0.2 | 0.7 | GO:0045657 | positive regulation of monocyte differentiation(GO:0045657) |
0.2 | 3.3 | GO:1900006 | positive regulation of dendrite development(GO:1900006) |
0.2 | 0.9 | GO:0033314 | mitotic DNA replication checkpoint(GO:0033314) |
0.2 | 0.2 | GO:0060166 | olfactory pit development(GO:0060166) |
0.2 | 0.7 | GO:0007191 | adenylate cyclase-activating dopamine receptor signaling pathway(GO:0007191) |
0.2 | 0.7 | GO:0002325 | natural killer cell differentiation involved in immune response(GO:0002325) negative regulation of natural killer cell differentiation(GO:0032824) regulation of natural killer cell differentiation involved in immune response(GO:0032826) negative regulation of natural killer cell differentiation involved in immune response(GO:0032827) |
0.2 | 1.9 | GO:0006182 | cGMP biosynthetic process(GO:0006182) |
0.2 | 0.9 | GO:0070633 | transepithelial transport(GO:0070633) |
0.2 | 0.5 | GO:0050862 | positive regulation of T cell receptor signaling pathway(GO:0050862) |
0.2 | 0.4 | GO:0090050 | positive regulation of cell migration involved in sprouting angiogenesis(GO:0090050) |
0.2 | 0.2 | GO:0060460 | left lung development(GO:0060459) left lung morphogenesis(GO:0060460) |
0.2 | 0.3 | GO:0015888 | thiamine transport(GO:0015888) |
0.2 | 2.7 | GO:0007405 | neuroblast proliferation(GO:0007405) |
0.2 | 0.7 | GO:0060011 | Sertoli cell proliferation(GO:0060011) |
0.2 | 0.3 | GO:0090135 | actin filament branching(GO:0090135) |
0.2 | 1.5 | GO:0015937 | coenzyme A biosynthetic process(GO:0015937) |
0.2 | 0.2 | GO:0048853 | forebrain morphogenesis(GO:0048853) |
0.2 | 0.2 | GO:0010751 | negative regulation of nitric oxide mediated signal transduction(GO:0010751) |
0.2 | 0.3 | GO:0097152 | mesenchymal cell apoptotic process(GO:0097152) |
0.2 | 0.2 | GO:1903297 | regulation of hypoxia-induced intrinsic apoptotic signaling pathway(GO:1903297) negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway(GO:1903298) |
0.2 | 0.3 | GO:2000343 | positive regulation of chemokine (C-X-C motif) ligand 2 production(GO:2000343) |
0.2 | 6.8 | GO:0050808 | synapse organization(GO:0050808) |
0.2 | 0.2 | GO:1900242 | regulation of synaptic vesicle endocytosis(GO:1900242) |
0.2 | 0.8 | GO:0015808 | L-alanine transport(GO:0015808) |
0.2 | 0.2 | GO:2001032 | regulation of double-strand break repair via nonhomologous end joining(GO:2001032) |
0.2 | 0.3 | GO:0070294 | renal sodium ion absorption(GO:0070294) |
0.2 | 0.2 | GO:0030210 | heparin biosynthetic process(GO:0030210) |
0.2 | 0.3 | GO:0071895 | odontoblast differentiation(GO:0071895) |
0.2 | 0.2 | GO:0019364 | pyridine nucleotide catabolic process(GO:0019364) |
0.2 | 0.2 | GO:0021548 | pons development(GO:0021548) |
0.2 | 0.3 | GO:0051280 | negative regulation of release of sequestered calcium ion into cytosol(GO:0051280) |
0.2 | 0.3 | GO:0033030 | negative regulation of neutrophil apoptotic process(GO:0033030) |
0.2 | 0.2 | GO:0072148 | epithelial cell fate commitment(GO:0072148) |
0.2 | 0.8 | GO:0006685 | sphingomyelin catabolic process(GO:0006685) |
0.2 | 0.5 | GO:0006296 | nucleotide-excision repair, DNA incision, 5'-to lesion(GO:0006296) |
0.2 | 0.5 | GO:0046113 | pyrimidine nucleobase catabolic process(GO:0006208) thymine catabolic process(GO:0006210) thymine metabolic process(GO:0019859) nucleobase catabolic process(GO:0046113) |
0.2 | 0.2 | GO:0060355 | positive regulation of cell adhesion molecule production(GO:0060355) |
0.1 | 0.1 | GO:0090526 | regulation of gluconeogenesis involved in cellular glucose homeostasis(GO:0090526) |
0.1 | 0.1 | GO:0097360 | chorionic trophoblast cell proliferation(GO:0097360) regulation of chorionic trophoblast cell proliferation(GO:1901382) |
0.1 | 0.4 | GO:0034638 | phosphatidylcholine catabolic process(GO:0034638) |
0.1 | 0.1 | GO:1902956 | regulation of mitochondrial electron transport, NADH to ubiquinone(GO:1902956) |
0.1 | 0.9 | GO:0060718 | chorionic trophoblast cell differentiation(GO:0060718) |
0.1 | 1.3 | GO:1904355 | positive regulation of telomere capping(GO:1904355) |
0.1 | 0.4 | GO:0072051 | juxtaglomerular apparatus development(GO:0072051) |
0.1 | 0.1 | GO:2000857 | positive regulation of mineralocorticoid secretion(GO:2000857) positive regulation of aldosterone secretion(GO:2000860) |
0.1 | 0.6 | GO:0032202 | telomere assembly(GO:0032202) |
0.1 | 0.4 | GO:0031652 | positive regulation of heat generation(GO:0031652) |
0.1 | 0.3 | GO:0035425 | autocrine signaling(GO:0035425) |
0.1 | 0.1 | GO:1904742 | regulation of telomeric DNA binding(GO:1904742) |
0.1 | 0.3 | GO:2000008 | regulation of protein localization to cell surface(GO:2000008) |
0.1 | 0.1 | GO:1903333 | negative regulation of protein folding(GO:1903333) |
0.1 | 0.1 | GO:0031914 | negative regulation of synaptic plasticity(GO:0031914) |
0.1 | 0.1 | GO:0051081 | membrane disassembly(GO:0030397) nuclear envelope disassembly(GO:0051081) |
0.1 | 0.5 | GO:0032793 | positive regulation of CREB transcription factor activity(GO:0032793) |
0.1 | 0.7 | GO:0051045 | negative regulation of membrane protein ectodomain proteolysis(GO:0051045) |
0.1 | 0.5 | GO:0035729 | response to hepatocyte growth factor(GO:0035728) cellular response to hepatocyte growth factor stimulus(GO:0035729) |
0.1 | 0.9 | GO:0032060 | bleb assembly(GO:0032060) |
0.1 | 0.7 | GO:1990564 | protein polyufmylation(GO:1990564) protein K69-linked ufmylation(GO:1990592) |
0.1 | 0.5 | GO:0033762 | response to glucagon(GO:0033762) |
0.1 | 0.5 | GO:0045404 | positive regulation of interleukin-4 biosynthetic process(GO:0045404) |
0.1 | 0.4 | GO:0048643 | positive regulation of skeletal muscle tissue development(GO:0048643) |
0.1 | 0.4 | GO:0010566 | regulation of ketone biosynthetic process(GO:0010566) |
0.1 | 0.3 | GO:0071236 | cellular response to antibiotic(GO:0071236) |
0.1 | 0.3 | GO:0008355 | olfactory learning(GO:0008355) |
0.1 | 0.3 | GO:0010966 | regulation of phosphate transport(GO:0010966) |
0.1 | 3.5 | GO:0002028 | regulation of sodium ion transport(GO:0002028) |
0.1 | 0.9 | GO:0006108 | malate metabolic process(GO:0006108) |
0.1 | 0.1 | GO:2000317 | negative regulation of T-helper 17 type immune response(GO:2000317) negative regulation of T-helper 17 cell differentiation(GO:2000320) |
0.1 | 0.6 | GO:0045836 | positive regulation of meiotic nuclear division(GO:0045836) |
0.1 | 0.7 | GO:1901550 | regulation of endothelial cell development(GO:1901550) regulation of establishment of endothelial barrier(GO:1903140) |
0.1 | 1.7 | GO:0021591 | ventricular system development(GO:0021591) |
0.1 | 0.1 | GO:0060746 | parental behavior(GO:0060746) |
0.1 | 0.4 | GO:0002538 | arachidonic acid metabolite production involved in inflammatory response(GO:0002538) leukotriene production involved in inflammatory response(GO:0002540) |
0.1 | 0.2 | GO:0071732 | cellular response to nitric oxide(GO:0071732) |
0.1 | 0.4 | GO:0048294 | negative regulation of isotype switching to IgE isotypes(GO:0048294) |
0.1 | 0.5 | GO:0002158 | osteoclast proliferation(GO:0002158) |
0.1 | 0.3 | GO:0032570 | response to progesterone(GO:0032570) |
0.1 | 0.5 | GO:0031936 | negative regulation of chromatin silencing(GO:0031936) |
0.1 | 0.5 | GO:0044597 | polyketide metabolic process(GO:0030638) aminoglycoside antibiotic metabolic process(GO:0030647) daunorubicin metabolic process(GO:0044597) doxorubicin metabolic process(GO:0044598) |
0.1 | 0.1 | GO:0035898 | parathyroid hormone secretion(GO:0035898) |
0.1 | 1.2 | GO:0061462 | protein localization to lysosome(GO:0061462) |
0.1 | 0.7 | GO:0042796 | snRNA transcription from RNA polymerase III promoter(GO:0042796) |
0.1 | 0.2 | GO:0002692 | negative regulation of cellular extravasation(GO:0002692) negative regulation of leukocyte tethering or rolling(GO:1903237) |
0.1 | 0.9 | GO:0006020 | inositol metabolic process(GO:0006020) |
0.1 | 0.7 | GO:0045056 | transcytosis(GO:0045056) |
0.1 | 2.9 | GO:0046847 | filopodium assembly(GO:0046847) |
0.1 | 0.1 | GO:0038033 | positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway(GO:0038033) |
0.1 | 0.7 | GO:0048745 | smooth muscle tissue development(GO:0048745) |
0.1 | 0.1 | GO:1903984 | positive regulation of TRAIL-activated apoptotic signaling pathway(GO:1903984) |
0.1 | 0.8 | GO:0035563 | positive regulation of chromatin binding(GO:0035563) |
0.1 | 0.7 | GO:0042760 | very long-chain fatty acid catabolic process(GO:0042760) |
0.1 | 0.2 | GO:0048319 | axial mesoderm morphogenesis(GO:0048319) |
0.1 | 0.2 | GO:0071799 | response to prostaglandin D(GO:0071798) cellular response to prostaglandin D stimulus(GO:0071799) |
0.1 | 0.1 | GO:0071639 | positive regulation of monocyte chemotactic protein-1 production(GO:0071639) |
0.1 | 0.1 | GO:0070460 | thyroid-stimulating hormone secretion(GO:0070460) |
0.1 | 0.4 | GO:0007256 | activation of JNKK activity(GO:0007256) |
0.1 | 0.2 | GO:2000152 | regulation of ubiquitin-specific protease activity(GO:2000152) |
0.1 | 0.1 | GO:0071605 | monocyte chemotactic protein-1 production(GO:0071605) regulation of monocyte chemotactic protein-1 production(GO:0071637) |
0.1 | 0.3 | GO:1902410 | mitotic cytokinetic process(GO:1902410) |
0.1 | 0.9 | GO:0051571 | positive regulation of histone H3-K4 methylation(GO:0051571) |
0.1 | 0.4 | GO:0002584 | negative regulation of antigen processing and presentation(GO:0002578) negative regulation of antigen processing and presentation of peptide antigen(GO:0002584) |
0.1 | 0.1 | GO:0043366 | beta selection(GO:0043366) |
0.1 | 0.3 | GO:0045144 | meiotic sister chromatid segregation(GO:0045144) meiotic sister chromatid cohesion(GO:0051177) |
0.1 | 0.1 | GO:2000909 | regulation of cholesterol import(GO:0060620) regulation of sterol import(GO:2000909) |
0.1 | 0.1 | GO:0032058 | positive regulation of translational initiation in response to stress(GO:0032058) |
0.1 | 0.3 | GO:0015959 | diadenosine polyphosphate metabolic process(GO:0015959) |
0.1 | 0.3 | GO:0034310 | primary alcohol catabolic process(GO:0034310) |
0.1 | 0.3 | GO:0019374 | galactolipid metabolic process(GO:0019374) |
0.1 | 1.2 | GO:0030497 | fatty acid elongation(GO:0030497) |
0.1 | 0.5 | GO:0010917 | negative regulation of mitochondrial membrane potential(GO:0010917) |
0.1 | 0.1 | GO:0016539 | intein-mediated protein splicing(GO:0016539) protein splicing(GO:0030908) |
0.1 | 0.1 | GO:0070562 | regulation of vitamin D receptor signaling pathway(GO:0070562) |
0.1 | 0.2 | GO:0003203 | endocardial cushion morphogenesis(GO:0003203) |
0.1 | 0.2 | GO:0010446 | response to alkaline pH(GO:0010446) |
0.1 | 0.4 | GO:0060317 | cardiac epithelial to mesenchymal transition(GO:0060317) |
0.1 | 0.1 | GO:0046881 | positive regulation of follicle-stimulating hormone secretion(GO:0046881) |
0.1 | 0.3 | GO:0030823 | regulation of cGMP metabolic process(GO:0030823) |
0.1 | 0.1 | GO:0021794 | thalamus development(GO:0021794) |
0.1 | 0.3 | GO:0032610 | interleukin-1 alpha production(GO:0032610) |
0.1 | 0.3 | GO:1901026 | ripoptosome assembly(GO:0097343) ripoptosome assembly involved in necroptotic process(GO:1901026) |
0.1 | 0.3 | GO:0070295 | renal water absorption(GO:0070295) |
0.1 | 0.3 | GO:0007066 | female meiosis sister chromatid cohesion(GO:0007066) |
0.1 | 0.5 | GO:0070431 | nucleotide-binding oligomerization domain containing signaling pathway(GO:0070423) nucleotide-binding oligomerization domain containing 2 signaling pathway(GO:0070431) |
0.1 | 0.3 | GO:0044838 | cell quiescence(GO:0044838) |
0.1 | 0.3 | GO:0019732 | antifungal humoral response(GO:0019732) |
0.1 | 0.2 | GO:0006655 | phosphatidylglycerol biosynthetic process(GO:0006655) |
0.1 | 0.2 | GO:1900126 | negative regulation of hyaluronan biosynthetic process(GO:1900126) |
0.1 | 0.2 | GO:0035962 | response to interleukin-13(GO:0035962) cellular response to interleukin-13(GO:0035963) |
0.1 | 0.1 | GO:2001279 | regulation of prostaglandin biosynthetic process(GO:0031392) regulation of unsaturated fatty acid biosynthetic process(GO:2001279) |
0.1 | 0.1 | GO:0051771 | negative regulation of nitric-oxide synthase biosynthetic process(GO:0051771) |
0.1 | 0.2 | GO:0000733 | DNA strand renaturation(GO:0000733) |
0.1 | 0.6 | GO:2000254 | regulation of male germ cell proliferation(GO:2000254) |
0.1 | 0.3 | GO:0006651 | diacylglycerol biosynthetic process(GO:0006651) |
0.1 | 0.4 | GO:0098789 | pre-mRNA cleavage required for polyadenylation(GO:0098789) |
0.1 | 0.1 | GO:0043587 | tongue morphogenesis(GO:0043587) |
0.1 | 0.1 | GO:0036005 | response to macrophage colony-stimulating factor(GO:0036005) cellular response to macrophage colony-stimulating factor stimulus(GO:0036006) |
0.1 | 0.1 | GO:0019336 | phenol-containing compound catabolic process(GO:0019336) |
0.1 | 3.0 | GO:0001580 | detection of chemical stimulus involved in sensory perception of bitter taste(GO:0001580) |
0.1 | 0.2 | GO:0042518 | negative regulation of tyrosine phosphorylation of Stat3 protein(GO:0042518) |
0.1 | 0.3 | GO:0010944 | negative regulation of transcription by competitive promoter binding(GO:0010944) |
0.1 | 0.1 | GO:0090365 | regulation of mRNA modification(GO:0090365) |
0.1 | 0.3 | GO:0003310 | pancreatic A cell differentiation(GO:0003310) |
0.1 | 0.3 | GO:0001696 | gastric acid secretion(GO:0001696) |
0.1 | 0.3 | GO:0035092 | sperm chromatin condensation(GO:0035092) |
0.1 | 0.5 | GO:0036037 | CD8-positive, alpha-beta T cell activation(GO:0036037) |
0.1 | 0.5 | GO:0030539 | male genitalia development(GO:0030539) |
0.1 | 0.1 | GO:0060594 | mammary gland specification(GO:0060594) |
0.1 | 0.1 | GO:0060431 | primary lung bud formation(GO:0060431) |
0.1 | 0.3 | GO:2000601 | positive regulation of Arp2/3 complex-mediated actin nucleation(GO:2000601) |
0.1 | 0.8 | GO:0015693 | magnesium ion transport(GO:0015693) |
0.1 | 0.1 | GO:0010958 | regulation of amino acid import(GO:0010958) |
0.1 | 0.2 | GO:0042136 | neurotransmitter biosynthetic process(GO:0042136) |
0.1 | 0.1 | GO:1900425 | negative regulation of defense response to bacterium(GO:1900425) |
0.1 | 0.1 | GO:0070949 | regulation of neutrophil mediated cytotoxicity(GO:0070948) regulation of neutrophil mediated killing of symbiont cell(GO:0070949) |
0.1 | 0.1 | GO:0002282 | microglial cell activation involved in immune response(GO:0002282) |
0.1 | 0.2 | GO:0090141 | positive regulation of mitochondrial fission(GO:0090141) |
0.1 | 0.1 | GO:0014051 | gamma-aminobutyric acid secretion(GO:0014051) |
0.1 | 0.3 | GO:1904262 | negative regulation of TORC1 signaling(GO:1904262) |
0.1 | 0.1 | GO:1901490 | regulation of lymphangiogenesis(GO:1901490) |
0.1 | 0.1 | GO:0060296 | regulation of cilium movement involved in cell motility(GO:0060295) regulation of cilium beat frequency involved in ciliary motility(GO:0060296) regulation of cilium-dependent cell motility(GO:1902019) |
0.1 | 0.8 | GO:0034587 | piRNA metabolic process(GO:0034587) |
0.1 | 2.4 | GO:0019369 | arachidonic acid metabolic process(GO:0019369) |
0.1 | 0.4 | GO:0033299 | secretion of lysosomal enzymes(GO:0033299) |
0.1 | 0.1 | GO:2000402 | negative regulation of lymphocyte migration(GO:2000402) |
0.1 | 0.1 | GO:0061209 | cell proliferation involved in mesonephros development(GO:0061209) |
0.1 | 0.3 | GO:0030388 | fructose 1,6-bisphosphate metabolic process(GO:0030388) |
0.1 | 0.1 | GO:0042161 | plasma lipoprotein particle oxidation(GO:0034441) lipoprotein modification(GO:0042160) lipoprotein oxidation(GO:0042161) |
0.1 | 0.3 | GO:0033033 | negative regulation of myeloid cell apoptotic process(GO:0033033) |
0.1 | 0.1 | GO:0032071 | regulation of endodeoxyribonuclease activity(GO:0032071) |
0.1 | 0.1 | GO:1902455 | negative regulation of stem cell population maintenance(GO:1902455) |
0.1 | 0.1 | GO:0045041 | protein import into mitochondrial intermembrane space(GO:0045041) |
0.0 | 0.1 | GO:1904667 | negative regulation of ubiquitin protein ligase activity(GO:1904667) |
0.0 | 0.1 | GO:0042699 | follicle-stimulating hormone signaling pathway(GO:0042699) |
0.0 | 0.0 | GO:0071816 | protein insertion into ER membrane(GO:0045048) tail-anchored membrane protein insertion into ER membrane(GO:0071816) |
0.0 | 0.0 | GO:0007412 | axon target recognition(GO:0007412) |
0.0 | 0.3 | GO:0002329 | pre-B cell differentiation(GO:0002329) |
0.0 | 0.1 | GO:0002408 | myeloid dendritic cell chemotaxis(GO:0002408) |
0.0 | 0.1 | GO:0006597 | spermine biosynthetic process(GO:0006597) |
0.0 | 0.8 | GO:0030890 | positive regulation of B cell proliferation(GO:0030890) |
0.0 | 0.0 | GO:0043497 | regulation of protein heterodimerization activity(GO:0043497) |
0.0 | 0.2 | GO:0010587 | miRNA catabolic process(GO:0010587) |
0.0 | 0.1 | GO:0045085 | negative regulation of interleukin-2 biosynthetic process(GO:0045085) |
0.0 | 0.1 | GO:0042940 | D-amino acid transport(GO:0042940) |
0.0 | 0.3 | GO:0071800 | podosome assembly(GO:0071800) |
0.0 | 0.0 | GO:0060167 | regulation of adenosine receptor signaling pathway(GO:0060167) |
0.0 | 0.0 | GO:0044332 | Wnt signaling pathway involved in dorsal/ventral axis specification(GO:0044332) |
0.0 | 0.1 | GO:0001555 | oocyte growth(GO:0001555) |
0.0 | 0.1 | GO:1903894 | regulation of IRE1-mediated unfolded protein response(GO:1903894) |
0.0 | 0.0 | GO:0061043 | regulation of vascular wound healing(GO:0061043) |
0.0 | 0.0 | GO:1903377 | negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903377) |
0.0 | 0.1 | GO:0090244 | Wnt signaling pathway involved in somitogenesis(GO:0090244) |
0.0 | 0.1 | GO:0050748 | negative regulation of lipoprotein metabolic process(GO:0050748) |
0.0 | 0.2 | GO:0051930 | regulation of sensory perception of pain(GO:0051930) regulation of sensory perception(GO:0051931) |
0.0 | 0.1 | GO:1900165 | negative regulation of interleukin-6 secretion(GO:1900165) |
0.0 | 0.1 | GO:0046952 | ketone body catabolic process(GO:0046952) |
0.0 | 0.1 | GO:0007341 | penetration of zona pellucida(GO:0007341) |
0.0 | 0.0 | GO:0014029 | neural crest formation(GO:0014029) |
0.0 | 0.1 | GO:0015755 | fructose transport(GO:0015755) |
0.0 | 0.1 | GO:0007210 | serotonin receptor signaling pathway(GO:0007210) |
0.0 | 0.0 | GO:0014831 | gastro-intestinal system smooth muscle contraction(GO:0014831) |
0.0 | 0.1 | GO:0034141 | positive regulation of toll-like receptor 3 signaling pathway(GO:0034141) |
0.0 | 0.1 | GO:0071043 | CUT catabolic process(GO:0071034) CUT metabolic process(GO:0071043) |
0.0 | 0.1 | GO:0035640 | exploration behavior(GO:0035640) |
0.0 | 0.0 | GO:0015705 | iodide transport(GO:0015705) |
0.0 | 0.0 | GO:0006295 | nucleotide-excision repair, DNA incision, 3'-to lesion(GO:0006295) |
0.0 | 0.1 | GO:0035584 | calcium-mediated signaling using intracellular calcium source(GO:0035584) |
0.0 | 0.2 | GO:0045899 | positive regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045899) |
0.0 | 0.1 | GO:0060335 | positive regulation of response to interferon-gamma(GO:0060332) positive regulation of interferon-gamma-mediated signaling pathway(GO:0060335) |
0.0 | 0.0 | GO:0006069 | ethanol metabolic process(GO:0006067) ethanol oxidation(GO:0006069) |
0.0 | 0.3 | GO:0009268 | response to pH(GO:0009268) |
0.0 | 0.1 | GO:0030091 | protein repair(GO:0030091) |
0.0 | 0.2 | GO:0046519 | sphingoid metabolic process(GO:0046519) |
0.0 | 0.9 | GO:0050911 | detection of chemical stimulus involved in sensory perception of smell(GO:0050911) |
0.0 | 0.1 | GO:0033504 | floor plate development(GO:0033504) |
0.0 | 0.1 | GO:0030204 | chondroitin sulfate metabolic process(GO:0030204) |
0.0 | 0.0 | GO:0060054 | positive regulation of epithelial cell proliferation involved in wound healing(GO:0060054) |
0.0 | 0.1 | GO:1900271 | regulation of long-term synaptic potentiation(GO:1900271) |
0.0 | 0.1 | GO:0048570 | notochord morphogenesis(GO:0048570) |
0.0 | 0.0 | GO:0045162 | clustering of voltage-gated sodium channels(GO:0045162) |
0.0 | 0.1 | GO:0009584 | detection of visible light(GO:0009584) |
0.0 | 0.1 | GO:0042253 | granulocyte macrophage colony-stimulating factor biosynthetic process(GO:0042253) regulation of granulocyte macrophage colony-stimulating factor biosynthetic process(GO:0045423) |
0.0 | 0.0 | GO:1904479 | negative regulation of intestinal absorption(GO:1904479) |
0.0 | 0.0 | GO:2000726 | negative regulation of cardiac muscle cell differentiation(GO:2000726) |
0.0 | 0.0 | GO:0060911 | cardiac cell fate commitment(GO:0060911) |
0.0 | 0.0 | GO:0051549 | regulation of keratinocyte migration(GO:0051547) positive regulation of keratinocyte migration(GO:0051549) |
0.0 | 0.0 | GO:0072017 | distal tubule development(GO:0072017) |
0.0 | 0.0 | GO:1903054 | negative regulation of extracellular matrix organization(GO:1903054) |
0.0 | 0.0 | GO:0002677 | negative regulation of chronic inflammatory response(GO:0002677) |
0.0 | 0.0 | GO:0032914 | positive regulation of transforming growth factor beta1 production(GO:0032914) |
0.0 | 0.0 | GO:0002086 | diaphragm contraction(GO:0002086) involuntary skeletal muscle contraction(GO:0003011) |
0.0 | 0.0 | GO:0046167 | glycerol-3-phosphate biosynthetic process(GO:0046167) |
0.0 | 0.1 | GO:0009624 | response to nematode(GO:0009624) |
0.0 | 0.1 | GO:0035726 | common myeloid progenitor cell proliferation(GO:0035726) |
0.0 | 0.0 | GO:0071838 | cell proliferation in bone marrow(GO:0071838) |
0.0 | 0.0 | GO:0090361 | platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
0.0 | 0.0 | GO:0051697 | protein delipidation(GO:0051697) |
0.0 | 0.0 | GO:0061470 | T follicular helper cell differentiation(GO:0061470) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.1 | 9.3 | GO:0097454 | Schwann cell microvillus(GO:0097454) |
2.6 | 23.0 | GO:0005883 | neurofilament(GO:0005883) |
2.5 | 7.4 | GO:0097648 | G-protein coupled receptor dimeric complex(GO:0038037) G-protein coupled receptor complex(GO:0097648) |
2.4 | 14.6 | GO:0016012 | sarcoglycan complex(GO:0016012) |
2.4 | 26.2 | GO:0043194 | axon initial segment(GO:0043194) |
2.1 | 4.2 | GO:0033010 | paranodal junction(GO:0033010) |
1.9 | 7.8 | GO:0070032 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin I complex(GO:0070032) |
1.8 | 3.5 | GO:1990635 | proximal dendrite(GO:1990635) |
1.7 | 17.4 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
1.7 | 5.1 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
1.7 | 6.6 | GO:0042567 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) insulin-like growth factor ternary complex(GO:0042567) |
1.6 | 4.9 | GO:0097427 | microtubule bundle(GO:0097427) |
1.5 | 12.3 | GO:0043083 | synaptic cleft(GO:0043083) |
1.5 | 4.6 | GO:1990812 | growth cone filopodium(GO:1990812) |
1.5 | 4.5 | GO:0014701 | junctional sarcoplasmic reticulum membrane(GO:0014701) |
1.5 | 4.5 | GO:0072534 | perineuronal net(GO:0072534) |
1.5 | 10.5 | GO:0032584 | growth cone membrane(GO:0032584) |
1.4 | 5.7 | GO:0017071 | intracellular cyclic nucleotide activated cation channel complex(GO:0017071) |
1.4 | 2.8 | GO:0044294 | dendritic growth cone(GO:0044294) |
1.3 | 13.4 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) |
1.3 | 6.6 | GO:0048787 | presynaptic active zone membrane(GO:0048787) |
1.3 | 11.7 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
1.3 | 2.5 | GO:0033647 | host intracellular organelle(GO:0033647) host intracellular membrane-bounded organelle(GO:0033648) |
1.2 | 25.8 | GO:0048786 | presynaptic active zone(GO:0048786) |
1.2 | 20.7 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
1.2 | 7.1 | GO:0031258 | lamellipodium membrane(GO:0031258) |
1.2 | 4.7 | GO:0032021 | NELF complex(GO:0032021) |
1.1 | 14.7 | GO:0032279 | asymmetric synapse(GO:0032279) |
1.1 | 2.2 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
1.1 | 6.6 | GO:0045180 | basal cortex(GO:0045180) |
1.1 | 3.2 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
1.1 | 40.9 | GO:0042734 | presynaptic membrane(GO:0042734) |
1.0 | 60.8 | GO:0008076 | voltage-gated potassium channel complex(GO:0008076) |
1.0 | 3.0 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
1.0 | 18.5 | GO:0032809 | neuronal cell body membrane(GO:0032809) |
1.0 | 1.9 | GO:0097025 | MPP7-DLG1-LIN7 complex(GO:0097025) |
0.9 | 24.4 | GO:0032281 | AMPA glutamate receptor complex(GO:0032281) |
0.9 | 10.1 | GO:0001527 | microfibril(GO:0001527) |
0.9 | 8.1 | GO:0035253 | ciliary rootlet(GO:0035253) |
0.9 | 2.7 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
0.9 | 3.4 | GO:0002142 | stereocilia ankle link complex(GO:0002142) |
0.8 | 9.3 | GO:0032433 | filopodium tip(GO:0032433) |
0.8 | 8.3 | GO:0097539 | ciliary transition fiber(GO:0097539) |
0.8 | 3.2 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
0.8 | 2.4 | GO:0031233 | intrinsic component of external side of plasma membrane(GO:0031233) |
0.8 | 8.1 | GO:0060091 | kinocilium(GO:0060091) |
0.8 | 2.3 | GO:0097487 | multivesicular body, internal vesicle(GO:0097487) |
0.8 | 0.8 | GO:0070033 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin II complex(GO:0070033) |
0.8 | 3.8 | GO:0030285 | integral component of synaptic vesicle membrane(GO:0030285) intrinsic component of synaptic vesicle membrane(GO:0098563) |
0.7 | 1.5 | GO:0098984 | symmetric synapse(GO:0032280) neuron to neuron synapse(GO:0098984) |
0.7 | 0.7 | GO:0070110 | ciliary neurotrophic factor receptor complex(GO:0070110) |
0.7 | 11.5 | GO:1902710 | GABA receptor complex(GO:1902710) GABA-A receptor complex(GO:1902711) |
0.7 | 5.5 | GO:0042788 | polysomal ribosome(GO:0042788) |
0.7 | 3.5 | GO:0031428 | box C/D snoRNP complex(GO:0031428) |
0.7 | 2.7 | GO:0005593 | FACIT collagen trimer(GO:0005593) |
0.6 | 1.9 | GO:0005608 | laminin-3 complex(GO:0005608) |
0.6 | 1.9 | GO:1990907 | beta-catenin-TCF complex(GO:1990907) |
0.6 | 1.9 | GO:0048179 | activin receptor complex(GO:0048179) |
0.6 | 87.8 | GO:0045211 | postsynaptic membrane(GO:0045211) |
0.6 | 2.4 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
0.6 | 3.5 | GO:0032590 | dendrite membrane(GO:0032590) |
0.6 | 7.2 | GO:0035686 | sperm fibrous sheath(GO:0035686) |
0.6 | 2.8 | GO:0030122 | AP-2 adaptor complex(GO:0030122) |
0.5 | 1.6 | GO:0032299 | ribonuclease H2 complex(GO:0032299) |
0.5 | 4.3 | GO:0097542 | ciliary tip(GO:0097542) |
0.5 | 18.1 | GO:0030315 | T-tubule(GO:0030315) |
0.5 | 4.7 | GO:0005859 | muscle myosin complex(GO:0005859) |
0.5 | 2.0 | GO:1990716 | axonemal central apparatus(GO:1990716) |
0.5 | 6.1 | GO:0031045 | dense core granule(GO:0031045) |
0.5 | 14.0 | GO:0043198 | dendritic shaft(GO:0043198) |
0.5 | 14.9 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
0.5 | 3.0 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
0.5 | 1.4 | GO:0043527 | tRNA methyltransferase complex(GO:0043527) |
0.5 | 1.4 | GO:0000802 | transverse filament(GO:0000802) |
0.4 | 1.3 | GO:0032133 | chromosome passenger complex(GO:0032133) |
0.4 | 2.7 | GO:0001674 | female germ cell nucleus(GO:0001674) |
0.4 | 1.3 | GO:0097149 | centralspindlin complex(GO:0097149) |
0.4 | 1.7 | GO:0045098 | type III intermediate filament(GO:0045098) |
0.4 | 1.7 | GO:0031313 | extrinsic component of endosome membrane(GO:0031313) |
0.4 | 3.9 | GO:0036156 | inner dynein arm(GO:0036156) |
0.4 | 1.3 | GO:0005955 | calcineurin complex(GO:0005955) |
0.4 | 2.1 | GO:0097433 | dense body(GO:0097433) |
0.4 | 1.7 | GO:1990851 | Wnt-Frizzled-LRP5/6 complex(GO:1990851) |
0.4 | 2.9 | GO:0036057 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
0.4 | 0.8 | GO:0030121 | AP-1 adaptor complex(GO:0030121) |
0.4 | 6.0 | GO:0005614 | interstitial matrix(GO:0005614) |
0.4 | 1.2 | GO:1990393 | 3M complex(GO:1990393) |
0.4 | 16.7 | GO:0030175 | filopodium(GO:0030175) |
0.4 | 1.1 | GO:0090498 | extrinsic component of Golgi membrane(GO:0090498) |
0.4 | 0.4 | GO:0044326 | dendritic spine neck(GO:0044326) |
0.4 | 2.2 | GO:0005915 | zonula adherens(GO:0005915) |
0.4 | 1.8 | GO:0044233 | ER-mitochondrion membrane contact site(GO:0044233) |
0.4 | 3.7 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
0.3 | 4.9 | GO:0097038 | perinuclear endoplasmic reticulum(GO:0097038) |
0.3 | 2.4 | GO:0044295 | axonal growth cone(GO:0044295) |
0.3 | 1.0 | GO:0035748 | myelin sheath abaxonal region(GO:0035748) |
0.3 | 1.0 | GO:0033268 | node of Ranvier(GO:0033268) |
0.3 | 1.3 | GO:0090665 | dystrophin-associated glycoprotein complex(GO:0016010) glycoprotein complex(GO:0090665) |
0.3 | 1.2 | GO:1990357 | terminal web(GO:1990357) |
0.3 | 2.7 | GO:0001891 | phagocytic cup(GO:0001891) |
0.3 | 3.5 | GO:0097431 | mitotic spindle pole(GO:0097431) |
0.3 | 2.8 | GO:0030061 | mitochondrial crista(GO:0030061) |
0.3 | 1.9 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
0.3 | 2.2 | GO:0005861 | troponin complex(GO:0005861) |
0.3 | 3.0 | GO:0045334 | clathrin-coated endocytic vesicle(GO:0045334) |
0.3 | 2.2 | GO:0001520 | outer dense fiber(GO:0001520) |
0.3 | 13.0 | GO:0001533 | cornified envelope(GO:0001533) |
0.3 | 1.8 | GO:0070187 | telosome(GO:0070187) |
0.3 | 0.5 | GO:0000322 | storage vacuole(GO:0000322) |
0.2 | 1.0 | GO:0030478 | actin cap(GO:0030478) |
0.2 | 0.7 | GO:0030289 | protein phosphatase 4 complex(GO:0030289) |
0.2 | 0.2 | GO:0035838 | growing cell tip(GO:0035838) |
0.2 | 0.7 | GO:0097441 | basilar dendrite(GO:0097441) |
0.2 | 25.8 | GO:0098794 | postsynapse(GO:0098794) |
0.2 | 1.7 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
0.2 | 1.0 | GO:0071547 | piP-body(GO:0071547) |
0.2 | 0.6 | GO:0071438 | invadopodium membrane(GO:0071438) |
0.2 | 1.5 | GO:0005869 | dynactin complex(GO:0005869) |
0.2 | 49.3 | GO:0005578 | proteinaceous extracellular matrix(GO:0005578) |
0.2 | 25.5 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.2 | 1.5 | GO:0005742 | mitochondrial outer membrane translocase complex(GO:0005742) |
0.2 | 0.7 | GO:0030314 | junctional membrane complex(GO:0030314) |
0.2 | 5.0 | GO:0005921 | gap junction(GO:0005921) |
0.2 | 5.1 | GO:0005581 | collagen trimer(GO:0005581) |
0.2 | 0.7 | GO:0030127 | COPII vesicle coat(GO:0030127) |
0.2 | 0.7 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
0.2 | 1.0 | GO:0035032 | phosphatidylinositol 3-kinase complex, class III(GO:0035032) |
0.2 | 0.5 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
0.1 | 0.4 | GO:0055087 | Ski complex(GO:0055087) |
0.1 | 3.4 | GO:0009925 | basal plasma membrane(GO:0009925) |
0.1 | 8.4 | GO:0030426 | growth cone(GO:0030426) |
0.1 | 0.4 | GO:0035355 | Toll-like receptor 2-Toll-like receptor 6 protein complex(GO:0035355) |
0.1 | 0.4 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
0.1 | 0.6 | GO:0034991 | nuclear meiotic cohesin complex(GO:0034991) |
0.1 | 0.4 | GO:0061689 | tricellular tight junction(GO:0061689) |
0.1 | 0.5 | GO:0097209 | epidermal lamellar body(GO:0097209) |
0.1 | 0.9 | GO:0005688 | U6 snRNP(GO:0005688) |
0.1 | 0.1 | GO:0044299 | C-fiber(GO:0044299) |
0.1 | 6.7 | GO:0031012 | extracellular matrix(GO:0031012) |
0.1 | 0.6 | GO:0089701 | U2AF(GO:0089701) |
0.1 | 1.0 | GO:0030991 | intraciliary transport particle A(GO:0030991) |
0.1 | 1.2 | GO:0033391 | chromatoid body(GO:0033391) |
0.1 | 0.3 | GO:0034457 | Mpp10 complex(GO:0034457) |
0.1 | 1.1 | GO:0042555 | MCM complex(GO:0042555) |
0.1 | 0.5 | GO:0099738 | cell cortex region(GO:0099738) |
0.1 | 1.6 | GO:0030140 | trans-Golgi network transport vesicle(GO:0030140) |
0.1 | 0.3 | GO:0035061 | interchromatin granule(GO:0035061) |
0.1 | 2.2 | GO:0048770 | melanosome(GO:0042470) pigment granule(GO:0048770) |
0.1 | 0.3 | GO:0070852 | cell body fiber(GO:0070852) |
0.1 | 0.2 | GO:0071546 | pi-body(GO:0071546) |
0.1 | 0.5 | GO:0071439 | clathrin complex(GO:0071439) |
0.1 | 0.4 | GO:0005579 | membrane attack complex(GO:0005579) |
0.1 | 0.3 | GO:0000408 | EKC/KEOPS complex(GO:0000408) |
0.1 | 0.2 | GO:0005956 | protein kinase CK2 complex(GO:0005956) |
0.1 | 1.2 | GO:0000930 | gamma-tubulin complex(GO:0000930) |
0.1 | 0.3 | GO:0043202 | lysosomal lumen(GO:0043202) |
0.1 | 0.1 | GO:0071008 | U2-type post-mRNA release spliceosomal complex(GO:0071008) |
0.1 | 0.1 | GO:0032010 | phagolysosome(GO:0032010) |
0.1 | 0.5 | GO:0034464 | BBSome(GO:0034464) |
0.1 | 0.5 | GO:0044666 | MLL3/4 complex(GO:0044666) |
0.1 | 0.3 | GO:0005890 | sodium:potassium-exchanging ATPase complex(GO:0005890) |
0.1 | 0.3 | GO:0001940 | male pronucleus(GO:0001940) |
0.1 | 0.3 | GO:0000138 | Golgi trans cisterna(GO:0000138) |
0.1 | 0.2 | GO:0072588 | box H/ACA snoRNP complex(GO:0031429) box H/ACA RNP complex(GO:0072588) |
0.1 | 0.2 | GO:0045293 | mRNA editing complex(GO:0045293) |
0.0 | 0.0 | GO:0030893 | meiotic cohesin complex(GO:0030893) |
0.0 | 0.1 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
0.0 | 0.0 | GO:1990909 | Wnt signalosome(GO:1990909) |
0.0 | 0.1 | GO:0071203 | WASH complex(GO:0071203) |
0.0 | 2.2 | GO:0043204 | perikaryon(GO:0043204) |
0.0 | 0.6 | GO:0005662 | DNA replication factor A complex(GO:0005662) |
0.0 | 0.1 | GO:0030891 | VCB complex(GO:0030891) |
0.0 | 0.3 | GO:0061700 | GATOR2 complex(GO:0061700) |
0.0 | 0.4 | GO:0044447 | axoneme part(GO:0044447) |
0.0 | 0.2 | GO:0070695 | FHF complex(GO:0070695) |
0.0 | 0.1 | GO:0005712 | chiasma(GO:0005712) |
0.0 | 0.1 | GO:0035363 | histone locus body(GO:0035363) |
0.0 | 0.4 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
0.0 | 1.5 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.0 | 0.1 | GO:0072687 | meiotic spindle(GO:0072687) |
0.0 | 0.1 | GO:0000347 | THO complex(GO:0000347) THO complex part of transcription export complex(GO:0000445) |
0.0 | 0.1 | GO:1990075 | periciliary membrane compartment(GO:1990075) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
5.0 | 15.0 | GO:0048101 | calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity(GO:0048101) |
3.5 | 10.4 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
3.4 | 13.7 | GO:0032051 | clathrin light chain binding(GO:0032051) |
3.2 | 9.6 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
3.0 | 12.0 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
3.0 | 11.9 | GO:0038064 | collagen receptor activity(GO:0038064) |
2.7 | 8.1 | GO:0005006 | epidermal growth factor-activated receptor activity(GO:0005006) |
2.6 | 10.5 | GO:0004065 | arylsulfatase activity(GO:0004065) |
2.6 | 10.4 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
2.6 | 7.7 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
2.5 | 5.1 | GO:0004886 | 9-cis retinoic acid receptor activity(GO:0004886) |
2.4 | 12.0 | GO:0086006 | voltage-gated sodium channel activity involved in cardiac muscle cell action potential(GO:0086006) |
2.3 | 9.3 | GO:0005030 | neurotrophin receptor activity(GO:0005030) |
2.3 | 11.3 | GO:0001601 | peptide YY receptor activity(GO:0001601) |
2.1 | 6.4 | GO:0005519 | cytoskeletal regulatory protein binding(GO:0005519) |
2.1 | 10.6 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
2.1 | 16.9 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
2.1 | 10.4 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
2.1 | 10.3 | GO:0086080 | protein binding involved in heterotypic cell-cell adhesion(GO:0086080) |
2.0 | 4.1 | GO:0097016 | L27 domain binding(GO:0097016) |
2.0 | 5.9 | GO:0008515 | sucrose:proton symporter activity(GO:0008506) sucrose transmembrane transporter activity(GO:0008515) disaccharide transmembrane transporter activity(GO:0015154) oligosaccharide transmembrane transporter activity(GO:0015157) |
1.8 | 8.9 | GO:0030550 | acetylcholine receptor inhibitor activity(GO:0030550) |
1.8 | 5.3 | GO:0004995 | tachykinin receptor activity(GO:0004995) |
1.6 | 29.6 | GO:0005112 | Notch binding(GO:0005112) |
1.6 | 11.4 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
1.5 | 7.7 | GO:0042609 | CD4 receptor binding(GO:0042609) |
1.5 | 7.6 | GO:0048495 | Roundabout binding(GO:0048495) |
1.5 | 7.3 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
1.5 | 11.6 | GO:0098988 | G-protein coupled glutamate receptor activity(GO:0098988) |
1.4 | 2.8 | GO:0086008 | voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization(GO:0086008) |
1.4 | 2.8 | GO:0004698 | calcium-dependent protein kinase C activity(GO:0004698) |
1.4 | 11.1 | GO:0008599 | protein phosphatase type 1 regulator activity(GO:0008599) |
1.4 | 2.7 | GO:0031697 | beta-1 adrenergic receptor binding(GO:0031697) |
1.4 | 2.7 | GO:0035373 | chondroitin sulfate proteoglycan binding(GO:0035373) |
1.3 | 5.3 | GO:0005042 | netrin receptor activity(GO:0005042) |
1.3 | 10.6 | GO:0005237 | inhibitory extracellular ligand-gated ion channel activity(GO:0005237) |
1.3 | 11.7 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
1.3 | 3.9 | GO:0030899 | calcium-dependent ATPase activity(GO:0030899) |
1.3 | 3.8 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
1.3 | 5.0 | GO:0034056 | estrogen response element binding(GO:0034056) |
1.2 | 39.7 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
1.2 | 6.1 | GO:0034481 | chondroitin sulfotransferase activity(GO:0034481) |
1.2 | 3.7 | GO:0050833 | pyruvate transmembrane transporter activity(GO:0050833) |
1.2 | 10.9 | GO:0042577 | lipid phosphatase activity(GO:0042577) |
1.2 | 3.5 | GO:0031708 | endothelin B receptor binding(GO:0031708) |
1.2 | 5.8 | GO:0008499 | UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity(GO:0008499) |
1.2 | 3.5 | GO:0019797 | procollagen-proline 3-dioxygenase activity(GO:0019797) |
1.2 | 7.0 | GO:0016907 | G-protein coupled acetylcholine receptor activity(GO:0016907) |
1.2 | 13.9 | GO:0015643 | toxic substance binding(GO:0015643) |
1.1 | 6.8 | GO:0008517 | folic acid transporter activity(GO:0008517) |
1.1 | 12.4 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
1.1 | 3.4 | GO:0004971 | AMPA glutamate receptor activity(GO:0004971) |
1.1 | 4.5 | GO:0048403 | brain-derived neurotrophic factor binding(GO:0048403) |
1.1 | 4.5 | GO:0070052 | collagen V binding(GO:0070052) |
1.1 | 4.4 | GO:0097001 | ceramide binding(GO:0097001) |
1.1 | 1.1 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
1.1 | 5.4 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
1.1 | 5.4 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
1.1 | 8.6 | GO:0031957 | very long-chain fatty acid-CoA ligase activity(GO:0031957) |
1.0 | 8.4 | GO:0004972 | NMDA glutamate receptor activity(GO:0004972) |
1.0 | 4.2 | GO:0005332 | gamma-aminobutyric acid:sodium symporter activity(GO:0005332) |
1.0 | 2.0 | GO:0098632 | protein binding involved in cell-cell adhesion(GO:0098632) |
1.0 | 28.4 | GO:0005272 | sodium channel activity(GO:0005272) |
1.0 | 5.0 | GO:0044323 | retinoic acid-responsive element binding(GO:0044323) |
1.0 | 10.0 | GO:0005003 | ephrin receptor activity(GO:0005003) |
1.0 | 4.0 | GO:0043121 | neurotrophin binding(GO:0043121) nerve growth factor binding(GO:0048406) |
1.0 | 2.0 | GO:0042392 | sphingosine-1-phosphate phosphatase activity(GO:0042392) |
1.0 | 19.5 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
1.0 | 10.5 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
1.0 | 5.7 | GO:0045545 | syndecan binding(GO:0045545) |
0.9 | 2.8 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
0.9 | 2.8 | GO:0034988 | Fc-gamma receptor I complex binding(GO:0034988) |
0.9 | 3.7 | GO:1904288 | BAT3 complex binding(GO:1904288) |
0.9 | 2.8 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
0.9 | 2.8 | GO:0031750 | D3 dopamine receptor binding(GO:0031750) |
0.9 | 4.5 | GO:0003958 | NADPH-hemoprotein reductase activity(GO:0003958) |
0.9 | 7.1 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
0.9 | 6.2 | GO:0031821 | G-protein coupled serotonin receptor binding(GO:0031821) |
0.9 | 3.5 | GO:0030280 | structural constituent of epidermis(GO:0030280) |
0.9 | 2.6 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
0.8 | 13.2 | GO:0015026 | coreceptor activity(GO:0015026) |
0.8 | 11.6 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.8 | 6.6 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
0.8 | 4.1 | GO:0017040 | ceramidase activity(GO:0017040) |
0.8 | 13.7 | GO:0004890 | GABA-A receptor activity(GO:0004890) |
0.8 | 11.0 | GO:0099589 | G-protein coupled serotonin receptor activity(GO:0004993) serotonin receptor activity(GO:0099589) |
0.8 | 3.8 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
0.8 | 2.3 | GO:0031871 | proteinase activated receptor binding(GO:0031871) |
0.8 | 0.8 | GO:0072345 | NAADP-sensitive calcium-release channel activity(GO:0072345) |
0.8 | 3.8 | GO:0008294 | calcium- and calmodulin-responsive adenylate cyclase activity(GO:0008294) |
0.8 | 0.8 | GO:0070326 | very-low-density lipoprotein particle receptor binding(GO:0070326) |
0.8 | 4.5 | GO:0016421 | CoA carboxylase activity(GO:0016421) |
0.8 | 3.8 | GO:0004111 | creatine kinase activity(GO:0004111) |
0.8 | 4.5 | GO:0019992 | diacylglycerol binding(GO:0019992) |
0.8 | 5.3 | GO:0015271 | outward rectifier potassium channel activity(GO:0015271) |
0.7 | 3.7 | GO:0008273 | calcium, potassium:sodium antiporter activity(GO:0008273) |
0.7 | 2.2 | GO:0004970 | ionotropic glutamate receptor activity(GO:0004970) |
0.7 | 7.2 | GO:0030955 | potassium ion binding(GO:0030955) |
0.7 | 19.5 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
0.7 | 2.1 | GO:0016909 | JUN kinase activity(GO:0004705) SAP kinase activity(GO:0016909) |
0.7 | 0.7 | GO:0048408 | epidermal growth factor binding(GO:0048408) |
0.7 | 0.7 | GO:0005347 | ATP transmembrane transporter activity(GO:0005347) |
0.7 | 4.0 | GO:0003747 | translation release factor activity(GO:0003747) translation termination factor activity(GO:0008079) |
0.7 | 10.7 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
0.7 | 1.3 | GO:0004351 | glutamate decarboxylase activity(GO:0004351) |
0.6 | 3.2 | GO:0034190 | apolipoprotein receptor binding(GO:0034190) |
0.6 | 5.7 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
0.6 | 17.6 | GO:0005245 | voltage-gated calcium channel activity(GO:0005245) |
0.6 | 17.5 | GO:0045296 | cadherin binding(GO:0045296) |
0.6 | 1.2 | GO:0032357 | oxidized DNA binding(GO:0032356) oxidized purine DNA binding(GO:0032357) |
0.6 | 1.9 | GO:0035673 | oligopeptide transmembrane transporter activity(GO:0035673) |
0.6 | 7.9 | GO:0015172 | acidic amino acid transmembrane transporter activity(GO:0015172) |
0.6 | 2.4 | GO:0005025 | transforming growth factor beta receptor activity, type I(GO:0005025) |
0.6 | 1.8 | GO:0033142 | progesterone receptor binding(GO:0033142) |
0.6 | 2.4 | GO:0016715 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen(GO:0016715) |
0.6 | 2.3 | GO:0035727 | lysophosphatidic acid binding(GO:0035727) |
0.6 | 1.7 | GO:0051033 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
0.6 | 3.4 | GO:0000983 | transcription factor activity, RNA polymerase II core promoter sequence-specific(GO:0000983) |
0.6 | 25.1 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
0.6 | 7.4 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
0.6 | 0.6 | GO:0016509 | long-chain-3-hydroxyacyl-CoA dehydrogenase activity(GO:0016509) |
0.6 | 15.0 | GO:0015459 | potassium channel regulator activity(GO:0015459) |
0.5 | 0.5 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
0.5 | 7.1 | GO:0022840 | leak channel activity(GO:0022840) narrow pore channel activity(GO:0022842) |
0.5 | 0.5 | GO:0004517 | nitric-oxide synthase activity(GO:0004517) |
0.5 | 11.4 | GO:0045499 | chemorepellent activity(GO:0045499) |
0.5 | 14.6 | GO:0017147 | Wnt-protein binding(GO:0017147) |
0.5 | 1.6 | GO:0008475 | procollagen-lysine 5-dioxygenase activity(GO:0008475) |
0.5 | 5.9 | GO:0015269 | calcium-activated potassium channel activity(GO:0015269) |
0.5 | 0.5 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
0.5 | 2.1 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
0.5 | 3.6 | GO:0003680 | AT DNA binding(GO:0003680) |
0.5 | 5.7 | GO:0031005 | filamin binding(GO:0031005) |
0.5 | 1.6 | GO:0003846 | 2-acylglycerol O-acyltransferase activity(GO:0003846) |
0.5 | 1.5 | GO:0000702 | oxidized base lesion DNA N-glycosylase activity(GO:0000702) |
0.5 | 1.5 | GO:0015198 | oligopeptide transporter activity(GO:0015198) |
0.5 | 1.5 | GO:0019871 | sodium channel inhibitor activity(GO:0019871) |
0.5 | 4.1 | GO:0070411 | I-SMAD binding(GO:0070411) |
0.5 | 2.5 | GO:0051185 | coenzyme transporter activity(GO:0051185) |
0.5 | 2.0 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
0.5 | 1.5 | GO:0000155 | phosphorelay sensor kinase activity(GO:0000155) |
0.5 | 7.3 | GO:0004889 | acetylcholine-activated cation-selective channel activity(GO:0004889) |
0.5 | 1.4 | GO:0016508 | long-chain-enoyl-CoA hydratase activity(GO:0016508) |
0.5 | 2.4 | GO:0102391 | decanoate--CoA ligase activity(GO:0102391) |
0.5 | 4.2 | GO:0047555 | 3',5'-cyclic-GMP phosphodiesterase activity(GO:0047555) |
0.5 | 1.9 | GO:0070051 | fibrinogen binding(GO:0070051) |
0.4 | 2.2 | GO:0016726 | xanthine dehydrogenase activity(GO:0004854) oxidoreductase activity, acting on CH or CH2 groups, NAD or NADP as acceptor(GO:0016726) |
0.4 | 1.3 | GO:0019166 | trans-2-enoyl-CoA reductase (NADPH) activity(GO:0019166) |
0.4 | 3.9 | GO:0030553 | cGMP binding(GO:0030553) |
0.4 | 5.2 | GO:0001161 | intronic transcription regulatory region sequence-specific DNA binding(GO:0001161) |
0.4 | 2.2 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
0.4 | 3.5 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
0.4 | 1.3 | GO:0035175 | histone kinase activity (H3-S10 specific)(GO:0035175) |
0.4 | 0.8 | GO:0015180 | L-alanine transmembrane transporter activity(GO:0015180) alanine transmembrane transporter activity(GO:0022858) |
0.4 | 11.6 | GO:0001540 | beta-amyloid binding(GO:0001540) |
0.4 | 4.1 | GO:0015386 | sodium:proton antiporter activity(GO:0015385) potassium:proton antiporter activity(GO:0015386) |
0.4 | 1.2 | GO:0008107 | galactoside 2-alpha-L-fucosyltransferase activity(GO:0008107) alpha-(1,2)-fucosyltransferase activity(GO:0031127) |
0.4 | 0.4 | GO:0008449 | N-acetylglucosamine-6-sulfatase activity(GO:0008449) |
0.4 | 4.3 | GO:0005351 | sugar:proton symporter activity(GO:0005351) |
0.4 | 1.2 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
0.4 | 2.3 | GO:0004931 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
0.4 | 1.2 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
0.4 | 1.2 | GO:0030297 | transmembrane receptor protein tyrosine kinase activator activity(GO:0030297) |
0.4 | 1.1 | GO:0030160 | GKAP/Homer scaffold activity(GO:0030160) |
0.4 | 1.5 | GO:0090482 | vitamin transmembrane transporter activity(GO:0090482) |
0.4 | 4.5 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.4 | 0.7 | GO:0004969 | histamine receptor activity(GO:0004969) |
0.4 | 1.5 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
0.4 | 3.3 | GO:0050811 | GABA receptor binding(GO:0050811) |
0.4 | 0.4 | GO:0046921 | alpha-(1->6)-fucosyltransferase activity(GO:0046921) |
0.4 | 1.1 | GO:0045503 | dynein light chain binding(GO:0045503) |
0.4 | 1.4 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
0.4 | 1.8 | GO:0004565 | beta-galactosidase activity(GO:0004565) |
0.4 | 1.4 | GO:0052833 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate 3-phosphatase activity(GO:0052832) inositol monophosphate 4-phosphatase activity(GO:0052833) inositol monophosphate phosphatase activity(GO:0052834) |
0.4 | 0.7 | GO:0004376 | glycolipid mannosyltransferase activity(GO:0004376) |
0.4 | 1.1 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
0.3 | 2.1 | GO:0046790 | virion binding(GO:0046790) |
0.3 | 1.7 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
0.3 | 2.7 | GO:0070700 | BMP receptor binding(GO:0070700) |
0.3 | 5.6 | GO:0005267 | potassium channel activity(GO:0005267) |
0.3 | 3.6 | GO:0001972 | retinoic acid binding(GO:0001972) |
0.3 | 2.9 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
0.3 | 7.2 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.3 | 1.0 | GO:0051373 | FATZ binding(GO:0051373) |
0.3 | 1.3 | GO:0008486 | diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) |
0.3 | 1.3 | GO:0004791 | thioredoxin-disulfide reductase activity(GO:0004791) |
0.3 | 1.3 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
0.3 | 8.8 | GO:0005184 | neuropeptide hormone activity(GO:0005184) |
0.3 | 1.2 | GO:0005280 | hydrogen:amino acid symporter activity(GO:0005280) |
0.3 | 1.5 | GO:0004385 | guanylate kinase activity(GO:0004385) |
0.3 | 3.1 | GO:0009881 | photoreceptor activity(GO:0009881) |
0.3 | 4.9 | GO:0042923 | neuropeptide binding(GO:0042923) |
0.3 | 0.9 | GO:0035939 | microsatellite binding(GO:0035939) |
0.3 | 0.9 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
0.3 | 6.8 | GO:0008188 | neuropeptide receptor activity(GO:0008188) |
0.3 | 0.9 | GO:0019211 | phosphatase activator activity(GO:0019211) |
0.3 | 29.0 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.3 | 1.5 | GO:0016494 | C-X-C chemokine receptor activity(GO:0016494) |
0.3 | 1.2 | GO:0055131 | C3HC4-type RING finger domain binding(GO:0055131) |
0.3 | 3.5 | GO:0019215 | intermediate filament binding(GO:0019215) |
0.3 | 2.3 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
0.3 | 8.8 | GO:0043425 | bHLH transcription factor binding(GO:0043425) |
0.3 | 0.3 | GO:0004367 | glycerol-3-phosphate dehydrogenase [NAD+] activity(GO:0004367) |
0.3 | 1.7 | GO:0005227 | calcium activated cation channel activity(GO:0005227) |
0.3 | 1.4 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
0.3 | 1.1 | GO:0038085 | vascular endothelial growth factor binding(GO:0038085) |
0.3 | 0.6 | GO:0001135 | transcription factor activity, RNA polymerase II transcription factor recruiting(GO:0001135) |
0.3 | 0.8 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
0.3 | 13.1 | GO:0008146 | sulfotransferase activity(GO:0008146) |
0.3 | 1.1 | GO:0008502 | melatonin receptor activity(GO:0008502) |
0.3 | 3.9 | GO:0051393 | alpha-actinin binding(GO:0051393) |
0.3 | 4.4 | GO:0071837 | HMG box domain binding(GO:0071837) |
0.3 | 2.6 | GO:0043733 | alkylbase DNA N-glycosylase activity(GO:0003905) DNA-3-methylbase glycosylase activity(GO:0043733) |
0.3 | 6.8 | GO:0016702 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen(GO:0016702) |
0.3 | 0.5 | GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity(GO:0015018) |
0.3 | 1.3 | GO:0016901 | oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor(GO:0016901) |
0.2 | 2.0 | GO:0015922 | aspartate oxidase activity(GO:0015922) |
0.2 | 1.5 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
0.2 | 0.2 | GO:0005502 | 11-cis retinal binding(GO:0005502) |
0.2 | 2.0 | GO:0051011 | microtubule minus-end binding(GO:0051011) |
0.2 | 1.0 | GO:0030229 | very-low-density lipoprotein particle receptor activity(GO:0030229) |
0.2 | 1.9 | GO:0051183 | vitamin transporter activity(GO:0051183) |
0.2 | 1.4 | GO:0005499 | vitamin D binding(GO:0005499) |
0.2 | 11.1 | GO:0042281 | dolichyl pyrophosphate Man9GlcNAc2 alpha-1,3-glucosyltransferase activity(GO:0042281) |
0.2 | 0.7 | GO:0008900 | hydrogen:potassium-exchanging ATPase activity(GO:0008900) |
0.2 | 0.9 | GO:0052794 | exo-alpha-sialidase activity(GO:0004308) alpha-sialidase activity(GO:0016997) exo-alpha-(2->3)-sialidase activity(GO:0052794) exo-alpha-(2->6)-sialidase activity(GO:0052795) exo-alpha-(2->8)-sialidase activity(GO:0052796) |
0.2 | 0.2 | GO:0038191 | neuropilin binding(GO:0038191) |
0.2 | 0.4 | GO:0030158 | protein xylosyltransferase activity(GO:0030158) |
0.2 | 4.0 | GO:0030507 | spectrin binding(GO:0030507) |
0.2 | 1.1 | GO:0001588 | dopamine neurotransmitter receptor activity, coupled via Gs(GO:0001588) |
0.2 | 0.6 | GO:0005275 | amine transmembrane transporter activity(GO:0005275) |
0.2 | 0.6 | GO:0033192 | calmodulin-dependent protein phosphatase activity(GO:0033192) |
0.2 | 0.6 | GO:0030284 | estrogen receptor activity(GO:0030284) |
0.2 | 0.4 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
0.2 | 0.8 | GO:0043495 | protein anchor(GO:0043495) |
0.2 | 0.8 | GO:0004459 | L-lactate dehydrogenase activity(GO:0004459) |
0.2 | 0.6 | GO:0008427 | calcium-dependent protein kinase inhibitor activity(GO:0008427) |
0.2 | 2.3 | GO:0005328 | neurotransmitter:sodium symporter activity(GO:0005328) |
0.2 | 0.4 | GO:0048763 | calcium-induced calcium release activity(GO:0048763) |
0.2 | 0.6 | GO:0031694 | alpha-2A adrenergic receptor binding(GO:0031694) |
0.2 | 1.0 | GO:0071723 | lipopeptide binding(GO:0071723) |
0.2 | 1.6 | GO:0015194 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
0.2 | 6.0 | GO:0005109 | frizzled binding(GO:0005109) |
0.2 | 0.6 | GO:0051380 | norepinephrine binding(GO:0051380) |
0.2 | 0.4 | GO:0015142 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) |
0.2 | 4.8 | GO:0015347 | sodium-independent organic anion transmembrane transporter activity(GO:0015347) |
0.2 | 0.4 | GO:0050815 | phosphoserine binding(GO:0050815) |
0.2 | 1.7 | GO:0008504 | monoamine transmembrane transporter activity(GO:0008504) |
0.2 | 1.0 | GO:0004758 | serine C-palmitoyltransferase activity(GO:0004758) |
0.2 | 0.7 | GO:0004083 | bisphosphoglycerate 2-phosphatase activity(GO:0004083) |
0.2 | 6.4 | GO:0016709 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen(GO:0016709) |
0.2 | 0.9 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
0.2 | 0.9 | GO:0016174 | NAD(P)H oxidase activity(GO:0016174) |
0.2 | 0.7 | GO:0016019 | N-acetylmuramoyl-L-alanine amidase activity(GO:0008745) peptidoglycan receptor activity(GO:0016019) |
0.2 | 0.4 | GO:0031893 | vasopressin receptor binding(GO:0031893) |
0.2 | 0.5 | GO:0019776 | Atg8 ligase activity(GO:0019776) |
0.2 | 0.2 | GO:0070697 | nodal binding(GO:0038100) activin receptor binding(GO:0070697) |
0.2 | 0.9 | GO:0030275 | LRR domain binding(GO:0030275) |
0.2 | 0.7 | GO:0043842 | Kdo transferase activity(GO:0043842) |
0.2 | 1.5 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
0.2 | 0.7 | GO:0018812 | 3-hydroxyacyl-CoA dehydratase activity(GO:0018812) |
0.2 | 2.2 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
0.2 | 0.5 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
0.2 | 0.8 | GO:0003847 | 1-alkyl-2-acetylglycerophosphocholine esterase activity(GO:0003847) |
0.2 | 1.0 | GO:0019855 | calcium channel inhibitor activity(GO:0019855) |
0.2 | 0.6 | GO:0034902 | alkyl sulfatase activity(GO:0018741) endosulfan hemisulfate sulfatase activity(GO:0034889) endosulfan sulfate hydrolase activity(GO:0034902) |
0.2 | 0.8 | GO:0031849 | olfactory receptor binding(GO:0031849) |
0.2 | 0.5 | GO:0008301 | DNA binding, bending(GO:0008301) |
0.2 | 0.2 | GO:0008532 | N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity(GO:0008532) |
0.1 | 1.2 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.1 | 0.3 | GO:0031402 | sodium ion binding(GO:0031402) alkali metal ion binding(GO:0031420) |
0.1 | 0.9 | GO:0016615 | malate dehydrogenase activity(GO:0016615) |
0.1 | 0.4 | GO:0003872 | 6-phosphofructokinase activity(GO:0003872) |
0.1 | 0.1 | GO:0008796 | bis(5'-nucleosyl)-tetraphosphatase activity(GO:0008796) |
0.1 | 3.8 | GO:0042169 | SH2 domain binding(GO:0042169) |
0.1 | 5.5 | GO:0008392 | arachidonic acid epoxygenase activity(GO:0008392) |
0.1 | 0.5 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
0.1 | 0.4 | GO:0051718 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) DNA (cytosine-5-)-methyltransferase activity, acting on CpG substrates(GO:0051718) |
0.1 | 1.5 | GO:0050750 | low-density lipoprotein particle receptor binding(GO:0050750) |
0.1 | 1.7 | GO:0032183 | SUMO binding(GO:0032183) |
0.1 | 1.3 | GO:0004707 | MAP kinase activity(GO:0004707) |
0.1 | 0.8 | GO:0050733 | RS domain binding(GO:0050733) |
0.1 | 0.4 | GO:0047045 | testosterone 17-beta-dehydrogenase (NADP+) activity(GO:0047045) |
0.1 | 0.6 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
0.1 | 4.6 | GO:0005546 | phosphatidylinositol-4,5-bisphosphate binding(GO:0005546) |
0.1 | 0.4 | GO:0035651 | AP-3 adaptor complex binding(GO:0035651) |
0.1 | 1.6 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
0.1 | 0.5 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
0.1 | 0.5 | GO:0004974 | leukotriene receptor activity(GO:0004974) |
0.1 | 1.5 | GO:0015106 | bicarbonate transmembrane transporter activity(GO:0015106) |
0.1 | 1.0 | GO:0038036 | sphingosine-1-phosphate receptor activity(GO:0038036) |
0.1 | 1.3 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
0.1 | 1.5 | GO:0004119 | calmodulin-dependent cyclic-nucleotide phosphodiesterase activity(GO:0004117) cGMP-stimulated cyclic-nucleotide phosphodiesterase activity(GO:0004118) cGMP-inhibited cyclic-nucleotide phosphodiesterase activity(GO:0004119) photoreceptor cyclic-nucleotide phosphodiesterase activity(GO:0004120) 7,8-dihydro-D-neopterin 2',3'-cyclic phosphate phosphodiesterase activity(GO:0044688) inositol phosphosphingolipid phospholipase activity(GO:0052712) inositol phosphorylceramide phospholipase activity(GO:0052713) mannosyl-inositol phosphorylceramide phospholipase activity(GO:0052714) mannosyl-diinositol phosphorylceramide phospholipase activity(GO:0052715) |
0.1 | 1.2 | GO:0005522 | profilin binding(GO:0005522) |
0.1 | 0.7 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
0.1 | 0.1 | GO:0004985 | opioid receptor activity(GO:0004985) |
0.1 | 0.2 | GO:0034711 | inhibin binding(GO:0034711) |
0.1 | 0.2 | GO:0016880 | acid-ammonia (or amide) ligase activity(GO:0016880) |
0.1 | 0.8 | GO:0003691 | double-stranded telomeric DNA binding(GO:0003691) |
0.1 | 1.0 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
0.1 | 4.7 | GO:0017022 | myosin binding(GO:0017022) |
0.1 | 0.3 | GO:0000340 | RNA 7-methylguanosine cap binding(GO:0000340) |
0.1 | 0.2 | GO:0004948 | calcitonin receptor activity(GO:0004948) |
0.1 | 0.7 | GO:0035014 | phosphatidylinositol 3-kinase regulator activity(GO:0035014) |
0.1 | 1.0 | GO:0000146 | microfilament motor activity(GO:0000146) |
0.1 | 0.5 | GO:0004523 | RNA-DNA hybrid ribonuclease activity(GO:0004523) |
0.1 | 0.2 | GO:0070878 | primary miRNA binding(GO:0070878) |
0.1 | 1.6 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
0.1 | 0.3 | GO:0031735 | CCR10 chemokine receptor binding(GO:0031735) |
0.1 | 1.0 | GO:0035250 | UDP-galactosyltransferase activity(GO:0035250) |
0.1 | 0.7 | GO:0010857 | calcium-dependent protein kinase activity(GO:0010857) |
0.1 | 0.5 | GO:0018856 | 3-oxo-2-(2'-pentenyl)cyclopentane-1-octanoic acid CoA ligase activity(GO:0010435) 3-isopropenyl-6-oxoheptanoyl-CoA synthetase activity(GO:0018854) 2-oxo-delta3-4,5,5-trimethylcyclopentenylacetyl-CoA synthetase activity(GO:0018855) benzoyl acetate-CoA ligase activity(GO:0018856) 2,4-dichlorobenzoate-CoA ligase activity(GO:0018857) pivalate-CoA ligase activity(GO:0034783) cyclopropanecarboxylate-CoA ligase activity(GO:0034793) adipate-CoA ligase activity(GO:0034796) citronellyl-CoA ligase activity(GO:0034823) mentha-1,3-dione-CoA ligase activity(GO:0034841) thiophene-2-carboxylate-CoA ligase activity(GO:0034842) 2,4,4-trimethylpentanoate-CoA ligase activity(GO:0034865) cis-2-methyl-5-isopropylhexa-2,5-dienoate-CoA ligase activity(GO:0034942) trans-2-methyl-5-isopropylhexa-2,5-dienoate-CoA ligase activity(GO:0034943) branched-chain acyl-CoA synthetase (ADP-forming) activity(GO:0043759) aryl-CoA synthetase (ADP-forming) activity(GO:0043762) 3-hydroxypropionyl-CoA synthetase activity(GO:0043955) perillic acid:CoA ligase (ADP-forming) activity(GO:0052685) perillic acid:CoA ligase (AMP-forming) activity(GO:0052686) (3R)-3-isopropenyl-6-oxoheptanoate:CoA ligase (ADP-forming) activity(GO:0052687) (3R)-3-isopropenyl-6-oxoheptanoate:CoA ligase (AMP-forming) activity(GO:0052688) pristanate-CoA ligase activity(GO:0070251) malonyl-CoA synthetase activity(GO:0090409) |
0.1 | 19.8 | GO:0001077 | transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001077) |
0.1 | 0.6 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.1 | 0.4 | GO:0019808 | polyamine binding(GO:0019808) |
0.1 | 1.2 | GO:0016500 | protein-hormone receptor activity(GO:0016500) |
0.1 | 0.7 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
0.1 | 1.5 | GO:0070888 | E-box binding(GO:0070888) |
0.1 | 0.2 | GO:0042289 | MHC class II protein binding(GO:0042289) |
0.1 | 0.2 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
0.1 | 10.3 | GO:0008022 | protein C-terminus binding(GO:0008022) |
0.1 | 0.2 | GO:0036033 | mediator complex binding(GO:0036033) |
0.1 | 0.5 | GO:0043023 | ribosomal large subunit binding(GO:0043023) |
0.1 | 0.4 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) |
0.1 | 2.1 | GO:0008009 | chemokine activity(GO:0008009) |
0.1 | 6.2 | GO:0008083 | growth factor activity(GO:0008083) |
0.1 | 0.3 | GO:0003910 | DNA ligase activity(GO:0003909) DNA ligase (ATP) activity(GO:0003910) |
0.1 | 1.9 | GO:0005080 | protein kinase C binding(GO:0005080) |
0.1 | 0.1 | GO:0004031 | aldehyde oxidase activity(GO:0004031) oxidoreductase activity, acting on the aldehyde or oxo group of donors, oxygen as acceptor(GO:0016623) |
0.1 | 0.2 | GO:0008898 | S-adenosylmethionine-homocysteine S-methyltransferase activity(GO:0008898) |
0.1 | 0.7 | GO:0016290 | palmitoyl-CoA hydrolase activity(GO:0016290) |
0.1 | 1.1 | GO:0005537 | mannose binding(GO:0005537) |
0.1 | 0.2 | GO:0003953 | NAD+ nucleosidase activity(GO:0003953) |
0.1 | 0.2 | GO:0019862 | IgA binding(GO:0019862) |
0.1 | 1.6 | GO:1990782 | protein tyrosine kinase binding(GO:1990782) |
0.0 | 0.1 | GO:0032190 | acrosin binding(GO:0032190) |
0.0 | 0.5 | GO:0017160 | Ral GTPase binding(GO:0017160) |
0.0 | 0.1 | GO:0042834 | peptidoglycan binding(GO:0042834) |
0.0 | 0.0 | GO:0031433 | telethonin binding(GO:0031433) |
0.0 | 0.2 | GO:0070883 | pre-miRNA binding(GO:0070883) |
0.0 | 0.1 | GO:0032767 | copper-dependent protein binding(GO:0032767) |
0.0 | 0.1 | GO:0018685 | alkane 1-monooxygenase activity(GO:0018685) |
0.0 | 0.1 | GO:0008260 | 3-oxoacid CoA-transferase activity(GO:0008260) |
0.0 | 0.1 | GO:0061133 | endopeptidase activator activity(GO:0061133) |
0.0 | 0.2 | GO:0016812 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides(GO:0016812) |
0.0 | 0.1 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.0 | 0.1 | GO:0047499 | calcium-independent phospholipase A2 activity(GO:0047499) |
0.0 | 0.0 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
0.0 | 2.0 | GO:0005179 | hormone activity(GO:0005179) |
0.0 | 0.1 | GO:0047961 | glycine N-acyltransferase activity(GO:0047961) |
0.0 | 0.0 | GO:0005402 | cation:sugar symporter activity(GO:0005402) |
0.0 | 0.2 | GO:0008376 | acetylgalactosaminyltransferase activity(GO:0008376) |
0.0 | 0.1 | GO:0004719 | protein-L-isoaspartate (D-aspartate) O-methyltransferase activity(GO:0004719) |
0.0 | 0.2 | GO:0036222 | XTP diphosphatase activity(GO:0036222) |
0.0 | 0.1 | GO:0004982 | N-formyl peptide receptor activity(GO:0004982) |
0.0 | 0.1 | GO:0004370 | glycerol kinase activity(GO:0004370) |
0.0 | 0.5 | GO:0033038 | bitter taste receptor activity(GO:0033038) |
0.0 | 0.1 | GO:0033691 | sialic acid binding(GO:0033691) |
0.0 | 0.8 | GO:0003777 | microtubule motor activity(GO:0003777) |
0.0 | 0.1 | GO:0003796 | lysozyme activity(GO:0003796) |
0.0 | 0.2 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.2 | 5.0 | PID INTEGRIN1 PATHWAY | Beta1 integrin cell surface interactions |
1.1 | 17.5 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.9 | 9.1 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.8 | 11.5 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.8 | 21.3 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
0.8 | 28.3 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
0.8 | 10.1 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.8 | 3.1 | PID S1P S1P2 PATHWAY | S1P2 pathway |
0.8 | 18.8 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.6 | 10.3 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.6 | 2.2 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
0.5 | 28.6 | PID NOTCH PATHWAY | Notch signaling pathway |
0.5 | 0.5 | PID S1P S1P3 PATHWAY | S1P3 pathway |
0.5 | 15.1 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.5 | 9.9 | PID EPHA FWDPATHWAY | EPHA forward signaling |
0.5 | 1.0 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.5 | 5.0 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
0.4 | 0.4 | PID VEGFR1 PATHWAY | VEGFR1 specific signals |
0.4 | 4.7 | PID ALK2 PATHWAY | ALK2 signaling events |
0.4 | 9.1 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
0.4 | 56.8 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.3 | 1.9 | PID REELIN PATHWAY | Reelin signaling pathway |
0.3 | 4.4 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
0.3 | 2.7 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.3 | 4.7 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.3 | 7.3 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.2 | 6.7 | SIG CHEMOTAXIS | Genes related to chemotaxis |
0.2 | 2.3 | PID S1P S1P1 PATHWAY | S1P1 pathway |
0.2 | 0.4 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
0.2 | 0.5 | PID CDC42 PATHWAY | CDC42 signaling events |
0.2 | 2.2 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.2 | 5.6 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
0.2 | 4.7 | PID BMP PATHWAY | BMP receptor signaling |
0.2 | 0.2 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
0.1 | 6.3 | NABA COLLAGENS | Genes encoding collagen proteins |
0.1 | 2.6 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.1 | 4.1 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.1 | 1.0 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.1 | 28.7 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
0.1 | 1.3 | PID LYSOPHOSPHOLIPID PATHWAY | LPA receptor mediated events |
0.1 | 0.4 | PID IL3 PATHWAY | IL3-mediated signaling events |
0.1 | 0.3 | PID EPO PATHWAY | EPO signaling pathway |
0.1 | 18.1 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.1 | 0.5 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.1 | 0.4 | PID CD40 PATHWAY | CD40/CD40L signaling |
0.1 | 0.3 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
0.1 | 0.2 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
0.1 | 0.6 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.0 | 0.1 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
0.0 | 0.0 | ST STAT3 PATHWAY | STAT3 Pathway |
0.0 | 0.0 | SA TRKA RECEPTOR | The TrkA receptor binds nerve growth factor to activate MAP kinase pathways and promote cell growth. |
0.0 | 0.1 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.0 | 0.0 | ST INTERLEUKIN 4 PATHWAY | Interleukin 4 (IL-4) Pathway |
0.0 | 0.0 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
0.0 | 0.1 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
0.0 | 0.1 | PID EPHB FWD PATHWAY | EPHB forward signaling |
0.0 | 0.1 | ST FAS SIGNALING PATHWAY | Fas Signaling Pathway |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.5 | 53.5 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
1.2 | 28.5 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
1.2 | 18.0 | REACTOME UNBLOCKING OF NMDA RECEPTOR GLUTAMATE BINDING AND ACTIVATION | Genes involved in Unblocking of NMDA receptor, glutamate binding and activation |
1.1 | 9.1 | REACTOME POTASSIUM CHANNELS | Genes involved in Potassium Channels |
1.1 | 46.9 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
1.0 | 11.4 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
1.0 | 31.8 | REACTOME INWARDLY RECTIFYING K CHANNELS | Genes involved in Inwardly rectifying K+ channels |
1.0 | 10.9 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
1.0 | 10.7 | REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
1.0 | 21.9 | REACTOME NITRIC OXIDE STIMULATES GUANYLATE CYCLASE | Genes involved in Nitric oxide stimulates guanylate cyclase |
0.9 | 19.0 | REACTOME LIGAND GATED ION CHANNEL TRANSPORT | Genes involved in Ligand-gated ion channel transport |
0.9 | 11.9 | REACTOME ENDOGENOUS STEROLS | Genes involved in Endogenous sterols |
0.9 | 0.9 | REACTOME SHC1 EVENTS IN EGFR SIGNALING | Genes involved in SHC1 events in EGFR signaling |
0.9 | 0.9 | REACTOME SIGNALING BY NOTCH3 | Genes involved in Signaling by NOTCH3 |
0.8 | 13.2 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.8 | 6.4 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
0.8 | 9.6 | REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
0.8 | 0.8 | REACTOME OLFACTORY SIGNALING PATHWAY | Genes involved in Olfactory Signaling Pathway |
0.7 | 9.7 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
0.7 | 2.2 | REACTOME REGULATED PROTEOLYSIS OF P75NTR | Genes involved in Regulated proteolysis of p75NTR |
0.7 | 8.0 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.7 | 2.0 | REACTOME RIP MEDIATED NFKB ACTIVATION VIA DAI | Genes involved in RIP-mediated NFkB activation via DAI |
0.6 | 10.6 | REACTOME INCRETIN SYNTHESIS SECRETION AND INACTIVATION | Genes involved in Incretin Synthesis, Secretion, and Inactivation |
0.6 | 1.8 | REACTOME ACETYLCHOLINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Acetylcholine Neurotransmitter Release Cycle |
0.6 | 6.5 | REACTOME HIGHLY CALCIUM PERMEABLE POSTSYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Highly calcium permeable postsynaptic nicotinic acetylcholine receptors |
0.6 | 13.2 | REACTOME ACTIVATED NOTCH1 TRANSMITS SIGNAL TO THE NUCLEUS | Genes involved in Activated NOTCH1 Transmits Signal to the Nucleus |
0.6 | 12.5 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.6 | 1.1 | REACTOME SOS MEDIATED SIGNALLING | Genes involved in SOS-mediated signalling |
0.5 | 4.1 | REACTOME THE ACTIVATION OF ARYLSULFATASES | Genes involved in The activation of arylsulfatases |
0.5 | 5.1 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
0.5 | 5.0 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
0.5 | 4.0 | REACTOME TRANSPORT OF ORGANIC ANIONS | Genes involved in Transport of organic anions |
0.5 | 5.2 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.5 | 4.1 | REACTOME HORMONE LIGAND BINDING RECEPTORS | Genes involved in Hormone ligand-binding receptors |
0.4 | 3.6 | REACTOME OPSINS | Genes involved in Opsins |
0.4 | 8.0 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
0.4 | 6.2 | REACTOME N GLYCAN ANTENNAE ELONGATION | Genes involved in N-Glycan antennae elongation |
0.4 | 7.8 | REACTOME CHONDROITIN SULFATE BIOSYNTHESIS | Genes involved in Chondroitin sulfate biosynthesis |
0.4 | 1.2 | REACTOME PRESYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Presynaptic nicotinic acetylcholine receptors |
0.4 | 1.6 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
0.4 | 8.9 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
0.4 | 4.1 | REACTOME TRAFFICKING OF GLUR2 CONTAINING AMPA RECEPTORS | Genes involved in Trafficking of GluR2-containing AMPA receptors |
0.4 | 3.0 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
0.4 | 7.3 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.3 | 4.2 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
0.3 | 1.6 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.3 | 6.0 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.3 | 3.6 | REACTOME EICOSANOID LIGAND BINDING RECEPTORS | Genes involved in Eicosanoid ligand-binding receptors |
0.3 | 7.2 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
0.3 | 3.7 | REACTOME CIRCADIAN REPRESSION OF EXPRESSION BY REV ERBA | Genes involved in Circadian Repression of Expression by REV-ERBA |
0.3 | 7.2 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
0.3 | 1.9 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
0.3 | 2.6 | REACTOME THE NLRP3 INFLAMMASOME | Genes involved in The NLRP3 inflammasome |
0.3 | 3.1 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
0.3 | 1.5 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
0.3 | 0.5 | REACTOME ADP SIGNALLING THROUGH P2RY12 | Genes involved in ADP signalling through P2Y purinoceptor 12 |
0.2 | 14.2 | REACTOME P75 NTR RECEPTOR MEDIATED SIGNALLING | Genes involved in p75 NTR receptor-mediated signalling |
0.2 | 2.9 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
0.2 | 5.3 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
0.2 | 0.5 | REACTOME SIGNALING BY ACTIVATED POINT MUTANTS OF FGFR1 | Genes involved in Signaling by activated point mutants of FGFR1 |
0.2 | 11.9 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.2 | 0.7 | REACTOME PLATELET SENSITIZATION BY LDL | Genes involved in Platelet sensitization by LDL |
0.2 | 4.9 | REACTOME IL RECEPTOR SHC SIGNALING | Genes involved in Interleukin receptor SHC signaling |
0.2 | 1.0 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 24 HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 24-hydroxycholesterol |
0.2 | 2.9 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
0.2 | 1.5 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.2 | 1.1 | REACTOME SHC MEDIATED SIGNALLING | Genes involved in SHC-mediated signalling |
0.2 | 1.2 | REACTOME PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS | Genes involved in Phosphorylation of CD3 and TCR zeta chains |
0.2 | 8.5 | REACTOME INTEGRIN CELL SURFACE INTERACTIONS | Genes involved in Integrin cell surface interactions |
0.2 | 1.2 | REACTOME CREATION OF C4 AND C2 ACTIVATORS | Genes involved in Creation of C4 and C2 activators |
0.2 | 0.7 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS | Genes involved in Synthesis of bile acids and bile salts |
0.2 | 1.9 | REACTOME FGFR4 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR4 ligand binding and activation |
0.2 | 0.2 | REACTOME ACYL CHAIN REMODELLING OF PC | Genes involved in Acyl chain remodelling of PC |
0.2 | 2.3 | REACTOME GLUCAGON TYPE LIGAND RECEPTORS | Genes involved in Glucagon-type ligand receptors |
0.2 | 8.9 | REACTOME TRANSMISSION ACROSS CHEMICAL SYNAPSES | Genes involved in Transmission across Chemical Synapses |
0.2 | 0.5 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
0.2 | 0.2 | REACTOME CELL CELL COMMUNICATION | Genes involved in Cell-Cell communication |
0.2 | 0.5 | REACTOME BETA DEFENSINS | Genes involved in Beta defensins |
0.2 | 0.9 | REACTOME PLATELET AGGREGATION PLUG FORMATION | Genes involved in Platelet Aggregation (Plug Formation) |
0.1 | 1.6 | REACTOME VITAMIN B5 PANTOTHENATE METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |
0.1 | 0.1 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
0.1 | 19.9 | REACTOME PEPTIDE LIGAND BINDING RECEPTORS | Genes involved in Peptide ligand-binding receptors |
0.1 | 1.0 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.1 | 3.6 | REACTOME MEIOTIC SYNAPSIS | Genes involved in Meiotic Synapsis |
0.1 | 0.4 | REACTOME CROSS PRESENTATION OF SOLUBLE EXOGENOUS ANTIGENS ENDOSOMES | Genes involved in Cross-presentation of soluble exogenous antigens (endosomes) |
0.1 | 6.2 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.1 | 0.9 | REACTOME A TETRASACCHARIDE LINKER SEQUENCE IS REQUIRED FOR GAG SYNTHESIS | Genes involved in A tetrasaccharide linker sequence is required for GAG synthesis |
0.1 | 1.2 | REACTOME RECRUITMENT OF NUMA TO MITOTIC CENTROSOMES | Genes involved in Recruitment of NuMA to mitotic centrosomes |
0.1 | 0.4 | REACTOME ER PHAGOSOME PATHWAY | Genes involved in ER-Phagosome pathway |
0.1 | 1.8 | REACTOME SYNTHESIS OF GLYCOSYLPHOSPHATIDYLINOSITOL GPI | Genes involved in Synthesis of glycosylphosphatidylinositol (GPI) |
0.1 | 0.5 | REACTOME GRB2 EVENTS IN ERBB2 SIGNALING | Genes involved in GRB2 events in ERBB2 signaling |
0.1 | 0.1 | REACTOME TRANSLOCATION OF ZAP 70 TO IMMUNOLOGICAL SYNAPSE | Genes involved in Translocation of ZAP-70 to Immunological synapse |
0.1 | 5.0 | REACTOME L1CAM INTERACTIONS | Genes involved in L1CAM interactions |
0.1 | 1.9 | REACTOME KINESINS | Genes involved in Kinesins |
0.1 | 1.4 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
0.1 | 0.9 | REACTOME BASE FREE SUGAR PHOSPHATE REMOVAL VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Base-free sugar-phosphate removal via the single-nucleotide replacement pathway |
0.1 | 2.4 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.1 | 0.2 | REACTOME PD1 SIGNALING | Genes involved in PD-1 signaling |
0.1 | 0.1 | REACTOME SIGNALING BY ERBB2 | Genes involved in Signaling by ERBB2 |
0.1 | 0.1 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.1 | 0.6 | REACTOME SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the late endosome membrane |
0.1 | 0.5 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
0.0 | 0.1 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
0.0 | 0.1 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.0 | 0.8 | REACTOME AMINE COMPOUND SLC TRANSPORTERS | Genes involved in Amine compound SLC transporters |
0.0 | 0.0 | REACTOME ADP SIGNALLING THROUGH P2RY1 | Genes involved in ADP signalling through P2Y purinoceptor 1 |
0.0 | 0.5 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
0.0 | 0.4 | REACTOME SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS | Genes involved in Synthesis of very long-chain fatty acyl-CoAs |
0.0 | 0.8 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
0.0 | 0.1 | REACTOME DESTABILIZATION OF MRNA BY AUF1 HNRNP D0 | Genes involved in Destabilization of mRNA by AUF1 (hnRNP D0) |
0.0 | 0.3 | REACTOME PLATELET CALCIUM HOMEOSTASIS | Genes involved in Platelet calcium homeostasis |
0.0 | 0.2 | REACTOME CD28 DEPENDENT PI3K AKT SIGNALING | Genes involved in CD28 dependent PI3K/Akt signaling |